data_1t0y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t0y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.531 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.538 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' HD13 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD11 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 . . . . . 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.441 HD22 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' CB ' ' HE3' ' A' ' 46' ' ' MET . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.414 ' HE3' ' CB ' ' A' ' 35' ' ' LEU . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 ' O ' HD11 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG21 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.643 HG21 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 3' ' ' GLU . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.626 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 12' ' ' ASN . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 HD21 HG21 ' A' ' 11' ' ' THR . 0.1 OUTLIER -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' ND2' ' HA3' ' A' ' 64' ' ' GLY . 63.6 m-80 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.49 ' H ' HG23 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.518 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.438 HD22 HD13 ' A' ' 61' ' ' LEU . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' THR . 76.7 t60 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 11' ' ' THR . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.508 ' HA ' ' HE2' ' A' ' 26' ' ' MET . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 81' ' ' ALA . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.665 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.665 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 12' ' ' ASN . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' HA ' ' OE2' ' A' ' 8' ' ' GLU . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HZ3' ' CD ' ' A' ' 36' ' ' GLU . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CD ' ' HZ3' ' A' ' 33' ' ' LYS . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' HG11 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 46' ' ' MET . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.42 ' OE1' ' HE2' ' A' ' 58' ' ' LYS 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HB2' HD21 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.616 ' O ' ' HB ' ' A' ' 62' ' ' THR . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' HH ' HD11 ' A' ' 68' ' ' LEU . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.652 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 HG11 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG21 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.652 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' HD23 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD11 ' HH ' ' A' ' 5' ' ' TYR . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' H ' HG21 ' A' ' 11' ' ' THR . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HB3' HG11 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 77' ' ' TYR . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' N ' HD21 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.679 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.518 ' HA ' ' HE2' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.51 ' H ' HG23 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.64 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 HD11 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.447 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.447 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.459 ' OE2' HG21 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG21 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.467 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' O ' HD11 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.58 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 64' ' ' GLY . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.513 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 . . . . . 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' HG ' ' A' ' 7' ' ' LEU . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.435 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 11' ' ' THR . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.516 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.4 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.724 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.724 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.57 ' HG1' ' CD ' ' A' ' 60' ' ' GLU 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.562 ' HA ' ' O ' ' A' ' 10' ' ' THR . 77.3 t60 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 47' ' ' ARG . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 40.9 tt0 . . . . . 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.466 ' HA ' ' HE1' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.648 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.489 ' H ' HG23 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.593 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 62' ' ' THR 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.581 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.644 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.582 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.465 ' H ' HG21 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 57' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.457 ' H ' HD21 ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.41 ' HG1' HG23 ' A' ' 41' ' ' THR . 10.1 m . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.5 ' OH ' HD11 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' H ' HG21 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 62' ' ' THR . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.494 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' NH2' HG22 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 57' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.55 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.578 ' O ' HG21 ' A' ' 62' ' ' THR 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.578 HG21 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD11 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.415 -2.196 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.523 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.619 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 63' ' ' ASP . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 7' ' ' LEU . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 69' ' ' LYS . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 . . . . . 0 CA--C 1.468 -2.207 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.449 ' CG2' ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HE2' ' CG2' ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.412 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 HE21 HD13 ' A' ' 57' ' ' LEU . 32.4 tp60 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.448 HD13 HE21 ' A' ' 49' ' ' GLN . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' HD23 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.508 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 18' ' ' MET . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.409 HG22 HD21 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 80' ' ' HIS . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' HD23 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.524 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 62' ' ' THR . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.46 HD11 ' CD2' ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.52 ' HD2' ' OE1' ' A' ' 49' ' ' GLN . 82.1 t60 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 45.1 tt0 . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.447 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.466 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 43' ' ' VAL . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 42' ' ' THR . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' THR . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.633 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.633 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.551 ' HB2' ' HH ' ' A' ' 5' ' ' TYR . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.641 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB2' HG22 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 57' ' ' LEU . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HB2' HD22 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.616 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HH ' ' A' ' 5' ' ' TYR . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.616 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.625 ' HB2' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 21' ' ' LYS . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' H ' HG23 ' A' ' 11' ' ' THR . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 21' ' ' LYS . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.637 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.486 ' HA ' ' HE1' ' A' ' 26' ' ' MET . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 28' ' ' LEU . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.53 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.3 m -87.88 135.98 33.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.48 126.26 43.97 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB2' ' OD1' ' A' ' 88' ' ' ASN . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.531 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.538 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' HD13 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD11 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -67.24 -30.97 71.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.75 79.89 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.754 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.87 72.46 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 114.214 0.445 . . . . 0.0 114.214 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 12' ' ' ASN . 26.0 t-20 -73.6 124.06 25.2 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.863 0.465 . . . . 0.0 111.929 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.58 3.33 0.65 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.709 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -86.09 113.4 22.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 -133.49 134.27 43.28 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.441 HD22 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.628 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' CB ' ' HE3' ' A' ' 46' ' ' MET . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.414 ' HE3' ' CB ' ' A' ' 35' ' ' LEU . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 ' O ' HD11 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG21 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.643 HG21 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 3' ' ' GLU . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.626 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.626 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 89' ' ' GLU . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' HB3' HD22 ' A' ' 88' ' ' ASN . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p -69.04 -26.67 65.09 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.24 80.43 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.382 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.57 29.19 74.37 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.319 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.501 HD22 ' HB3' ' A' ' 83' ' ' ASP . 5.7 p30 -96.41 135.59 38.08 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 122.612 -0.346 . . . . 0.0 110.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' HB2' HG23 ' A' ' 82' ' ' VAL . 15.2 mm-40 65.25 13.05 8.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.862 1.265 . . . . 0.0 110.383 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.82 -179.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.0 m -87.19 113.2 22.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -160.15 139.44 10.91 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.513 HG21 HD21 ' A' ' 12' ' ' ASN . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 HD21 HG21 ' A' ' 11' ' ' THR . 0.1 OUTLIER -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' ND2' ' HA3' ' A' ' 64' ' ' GLY . 63.6 m-80 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.49 ' H ' HG23 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.518 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.613 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.613 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.438 HD22 HD13 ' A' ' 61' ' ' LEU . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' THR . 76.7 t60 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.27 -31.73 62.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.08 71.88 Favored Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.674 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.63 42.98 45.43 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.733 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.14 126.94 31.77 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 62.86 21.52 12.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.911 0.884 . . . . 0.0 110.776 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.566 -178.211 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mtp . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p -75.65 111.7 11.25 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -157.77 121.12 4.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 11' ' ' THR . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.508 ' HA ' ' HE2' ' A' ' 26' ' ' MET . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.449 ' H ' HG23 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 81' ' ' ALA . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.665 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.665 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 89' ' ' GLU . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -32.04 73.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.07 2.09 85.23 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.28 20.79 73.6 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-O 121.406 0.448 . . . . 0.0 112.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -97.07 137.37 36.24 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.137 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.425 ' HB2' HG23 ' A' ' 82' ' ' VAL . 8.7 mm-40 60.77 31.62 20.1 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 109.773 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.437 -1.121 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -178.076 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.5 p -68.41 112.92 5.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -136.73 100.68 4.39 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 -172.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' HA ' ' OE2' ' A' ' 8' ' ' GLU . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HZ3' ' CD ' ' A' ' 36' ' ' GLU . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' CD ' ' HZ3' ' A' ' 33' ' ' LYS . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' HG11 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.452 HD13 ' SD ' ' A' ' 46' ' ' MET . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.42 ' OE1' ' HE2' ' A' ' 58' ' ' LYS 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HB2' HD21 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.616 ' O ' ' HB ' ' A' ' 62' ' ' THR . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.435 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 88' ' ' ASN . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -68.33 -32.74 73.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.6 15.69 34.76 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.794 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.96 47.47 90.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 91.1 m-20 -93.07 142.52 27.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.055 0.142 . . . . 0.0 111.114 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 64.5 19.66 11.88 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.905 0.882 . . . . 0.0 112.185 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.622 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.687 0.28 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -72.59 113.02 9.17 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.584 0.706 . . . . 0.0 109.229 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 -149.23 137.87 21.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' HH ' HD11 ' A' ' 68' ' ' LEU . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.652 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 HG11 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG21 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.652 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' HD23 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD11 ' HH ' ' A' ' 5' ' ' TYR . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.426 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m -76.53 -35.54 58.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.64 -4.31 30.19 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.85 65.53 2.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.797 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -93.38 160.24 14.9 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.363 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 66.09 71.92 0.4 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.592 1.187 . . . . 0.0 108.529 -171.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 C--N 1.296 -1.742 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.753 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.241 0.62 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.4 t -94.91 112.11 23.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.32 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.19 133.46 31.41 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.152 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.424 HD21 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' H ' HG21 ' A' ' 11' ' ' THR . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.605 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HB3' HG11 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 77' ' ' TYR . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' N ' HD21 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.679 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -66.24 -24.9 66.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.03 -5.07 81.18 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.54 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.57 -9.34 8.22 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 113.755 0.262 . . . . 0.0 113.755 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -99.61 147.72 25.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 122.29 0.236 . . . . 0.0 110.802 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HB3' ' HE2' ' A' ' 80' ' ' HIS . 11.7 mm-40 62.61 24.68 14.7 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.179 0.924 . . . . 0.0 111.821 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.033 -179.013 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.2 m -91.92 112.95 25.08 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.33 92.86 2.3 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.518 ' HA ' ' HE2' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.51 ' H ' HG23 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.554 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.64 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.64 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 HD11 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.447 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m -79.64 -34.46 40.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.25 -0.56 33.31 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.31 70.37 1.09 Allowed Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.325 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.21 143.36 27.37 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.273 -0.545 . . . . 0.0 109.781 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 63.9 92.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.37 1.044 . . . . 0.0 111.724 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.207 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.4 p -84.04 113.91 21.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.1 0.476 . . . . 0.0 110.182 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 -159.93 158.82 31.45 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.459 ' OE2' HG21 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG21 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.467 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' O ' HD11 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.58 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 64' ' ' GLY . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.513 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -65.38 -31.83 73.15 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.44 7.65 80.06 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.696 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 38.49 93.34 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -83.14 130.6 35.12 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.424 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.349 11.6 pt-20 60.45 -34.74 0.08 Allowed 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 127.335 2.254 . . . . 0.0 116.949 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -99.56 136.85 38.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.333 0.396 . . . . 0.0 111.162 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 -115.9 136.25 53.22 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' HG ' ' A' ' 7' ' ' LEU . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.435 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 11' ' ' THR . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.516 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.724 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.724 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.57 ' HG1' ' CD ' ' A' ' 60' ' ' GLU 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.562 ' HA ' ' O ' ' A' ' 10' ' ' THR . 77.3 t60 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 47' ' ' ARG . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m -66.47 -32.1 73.26 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.04 1.6 74.28 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.649 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.58 31.64 80.54 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.23 148.42 39.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 71.33 69.44 0.17 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.324 1.449 . . . . 0.0 112.05 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 113.096 -1.866 . . . . 0.0 106.309 178.558 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 CA--C 1.494 -1.173 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -75.46 112.93 12.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 24' ' ' ALA . 40.9 tt0 -100.54 67.12 1.28 Allowed 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 -168.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 89' ' ' GLU . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.466 ' HA ' ' HE1' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.648 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.489 ' H ' HG23 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.593 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 62' ' ' THR 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.581 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.581 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -84.51 -31.75 24.3 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.9 -1.69 56.15 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.04 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.8 -136.13 35.7 Favored Glycine 0 C--O 1.212 -1.273 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -99.01 121.72 41.33 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.364 1.082 . . . . 0.0 111.9 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 13' ' ' ALA . 43.8 mt-10 52.49 85.2 0.05 OUTLIER 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.023 1.329 . . . . 0.0 113.771 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.266 177.641 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -94.22 112.81 24.64 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 -135.96 143.94 45.14 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' LYS . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.582 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.465 ' H ' HG21 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 57' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.457 ' H ' HD21 ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.41 ' HG1' HG23 ' A' ' 41' ' ' THR . 10.1 m -71.9 -33.47 68.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.17 9.37 54.24 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.32 39.69 98.07 Favored Glycine 0 CA--C 1.5 -0.858 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.53 123.44 34.94 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.086 0.469 . . . . 0.0 111.309 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.41 12.0 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.764 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.388 178.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -97.93 116.66 30.59 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.824 0.821 . . . . 0.0 111.863 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -136.18 132.35 35.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.5 ' OH ' HD11 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' H ' HG21 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 62' ' ' THR . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.494 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' NH2' HG22 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 57' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.627 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.55 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.578 ' O ' HG21 ' A' ' 62' ' ' THR 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.578 HG21 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD11 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 -35.05 13.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.46 -3.44 29.05 Favored Glycine 0 CA--C 1.474 -2.51 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 83' ' ' ASP . . . -93.68 141.3 15.47 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 114.144 -1.028 . . . . 0.0 111.419 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -100.88 144.97 29.19 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 120.915 0.388 . . . . 0.0 111.72 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.44 18.76 3.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 166.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 C--O 1.258 1.512 0 CA-C-N 111.925 -2.398 . . . . 0.0 107.99 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -78.55 113.7 16.81 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -117.65 133.76 55.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.48 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.523 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.619 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 63' ' ' ASP . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 ' CG1' HD13 ' A' ' 7' ' ' LEU . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -81.39 -32.07 32.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.84 -2.98 60.94 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.489 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.66 21.7 79.46 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.71 139.1 38.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.067 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 66.06 15.63 10.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.672 1.189 . . . . 0.0 111.79 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.284 -176.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.237 0.399 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -99.55 120.2 39.26 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.32 71.54 1.47 Allowed 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 69' ' ' LYS . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t -85.64 -32.09 22.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.73 -5.15 60.13 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.01 -167.42 21.94 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.7 -0.75 . . . . 0.0 114.032 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.85 128.66 45.93 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.959 0.409 . . . . 0.0 111.38 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.46 9.88 37.49 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.003 0.906 . . . . 0.0 110.411 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.872 178.062 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -88.25 113.15 23.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -169.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 -159.84 101.18 1.45 Allowed 'General case' 0 CA--C 1.468 -2.207 0 C-N-CA 127.303 2.241 . . . . 0.0 107.585 169.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.449 ' CG2' ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' A' ' 88' ' ' ASN . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HE2' ' CG2' ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.412 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.408 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 HE21 HD13 ' A' ' 57' ' ' LEU . 32.4 tp60 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.448 HD13 HE21 ' A' ' 49' ' ' GLN . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB2' HD23 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.508 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t -66.36 -32.49 73.91 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.57 -2.74 40.58 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.3 39.75 65.79 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 114.733 -0.733 . . . . 0.0 112.117 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.456 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 37.0 m-80 -86.62 121.65 29.44 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.634 -177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.35 21.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.811 1.291 . . . . 0.0 108.177 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.304 -175.686 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 p -91.45 110.88 22.19 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 -151.16 106.52 3.34 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.477 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 18' ' ' MET . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.496 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.564 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.409 HG22 HD21 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 80' ' ' HIS . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' HD23 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.524 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.593 ' O ' HG23 ' A' ' 62' ' ' THR . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.46 HD11 ' CD2' ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.52 ' HD2' ' OE1' ' A' ' 49' ' ' GLN . 82.1 t60 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -93.25 -32.64 14.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.8 -0.28 56.4 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.714 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.86 170.39 44.36 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -81.7 135.41 35.51 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.58 91.68 0.09 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.963 1.305 . . . . 0.0 112.979 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 172.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.5 m -76.9 111.92 12.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 45.1 tt0 -156.49 113.33 3.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.672 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.469 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.407 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.466 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 43' ' ' VAL . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 42' ' ' THR . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' THR . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.633 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.633 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.551 ' HB2' ' HH ' ' A' ' 5' ' ' TYR . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p -65.26 -26.42 68.09 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.83 -4.19 79.33 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.251 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.29 47.4 89.93 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -92.82 126.69 38.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.658 -0.271 . . . . 0.0 110.708 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 41.87 53.45 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.326 1.45 . . . . 0.0 114.527 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.402 -2.865 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.111 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 p -87.01 112.61 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.329 0.585 . . . . 0.0 110.264 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 -160.55 93.13 1.0 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.641 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.591 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.625 ' SD ' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 57' ' ' LEU . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HB2' HD22 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.616 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HH ' ' A' ' 5' ' ' TYR . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.616 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.625 ' HB2' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -73.9 -31.37 63.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.16 -4.07 72.03 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.574 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.26 171.37 9.6 Favored Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.287 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.547 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.8 t-20 -83.08 122.94 28.99 Favored 'General case' 0 N--CA 1.42 -1.964 0 O-C-N 122.171 -0.605 . . . . 0.0 110.148 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 50.4 81.47 0.06 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.957 -178.272 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 p -99.11 111.87 24.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.968 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 -111.84 150.03 30.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 21' ' ' LYS . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.598 ' ND2' HD21 ' A' ' 88' ' ' ASN . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 21' ' ' LYS . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.637 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.486 ' HA ' ' HE1' ' A' ' 26' ' ' MET . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 28' ' ' LEU . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.551 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.412 ' HA ' ' HE3' ' A' ' 46' ' ' MET . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.53 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -84.91 -33.72 22.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.46 -0.0 32.78 Favored Glycine 0 CA--C 1.48 -2.153 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.69 38.35 87.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.598 HD21 ' ND2' ' A' ' 12' ' ' ASN . 7.9 t30 -85.19 130.84 34.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -175.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 67.33 84.39 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 O-C-N 124.059 0.849 . . . . 0.0 109.818 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.612 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 68' ' ' LEU . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.426 HG12 HD22 ' A' ' 7' ' ' LEU . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 . . . . . 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.454 ' CG1' HD23 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' LYS . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 83' ' ' ASP . 27.8 p-10 -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 4' ' ' VAL . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.415 ' OD1' ' HA3' ' A' ' 64' ' ' GLY . 29.3 m120 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.579 ' H ' HG22 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HE2' ' A' ' 66' ' ' LYS . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 50' ' ' LEU . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 10' ' ' THR . 35.7 t-80 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 82' ' ' VAL . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.549 ' HE2' ' H ' ' A' ' 27' ' ' SER . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.549 ' H ' ' HE2' ' A' ' 26' ' ' MET . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 79' ' ' ILE . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD12 HG22 ' A' ' 73' ' ' VAL . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.677 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' HB2' ' A' ' 7' ' ' LEU . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 12' ' ' ASN . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 33.8 mt-10 . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.456 HG23 ' HG1' ' A' ' 85' ' ' THR . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.639 HG22 HD23 ' A' ' 61' ' ' LEU . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' HE22 ' A' ' 56' ' ' GLN . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 52' ' ' ASP 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HB2' HD22 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 48' ' ' ILE . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 HD23 ' A' ' 7' ' ' LEU . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HG1' HG23 ' A' ' 41' ' ' THR . 5.2 m . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.504 ' HB2' ' N ' ' A' ' 75' ' ' ASP . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.657 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.638 HG22 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 32' ' ' LYS . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.657 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG13 ' HD3' ' A' ' 32' ' ' LYS . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' CB ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB2' HD21 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 26' ' ' MET . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.454 ' HB3' HD21 ' A' ' 50' ' ' LEU . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB3' HG23 ' A' ' 82' ' ' VAL . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.575 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.537 HG13 HD13 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' NE2' HD11 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.459 ' N ' HD23 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.571 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.524 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.693 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CD2' HD21 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 24' ' ' ALA . 35.1 tt0 . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 6' ' ' ASP . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.527 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' HE2' ' A' ' 26' ' ' MET . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 32' ' ' LYS . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.681 ' H ' ' HG ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.648 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD13 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 79' ' ' ILE . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' OE2' HG22 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' HG13 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 HE22 HG11 ' A' ' 82' ' ' VAL . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 57' ' ' LEU . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.585 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' GLY . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 7' ' ' LEU . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.522 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 . . . . . 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' HB3' HG23 ' A' ' 82' ' ' VAL . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 11' ' ' THR . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.738 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 32' ' ' LYS . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 61' ' ' LEU . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.738 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 50' ' ' LEU . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 48' ' ' ILE . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' THR . 42.1 t-80 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 11' ' ' THR . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 40.9 tt0 . . . . . 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 14' ' ' THR . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.445 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 26' ' ' MET . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.609 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 82' ' ' VAL . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.412 ' H ' ' H ' ' A' ' 55' ' ' ASP . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 61' ' ' LEU 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' HD21 ' A' ' 71' ' ' LEU . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 63' ' ' ASP . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.599 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG22 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 HD21 ' A' ' 61' ' ' LEU . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB2' HD22 ' A' ' 61' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 m . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.51 ' OH ' HD13 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.465 ' H ' ' HA2' ' A' ' 64' ' ' GLY . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG13 ' HD3' ' A' ' 32' ' ' LYS . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.543 ' CE ' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB2' HD22 ' A' ' 61' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 61' ' ' LEU 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 28' ' ' LEU . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD13 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG21 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.415 -2.196 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.447 HD13 ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 73' ' ' VAL . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.559 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 61' ' ' LEU . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 9' ' ' ILE . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.3 t . . . . . 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.533 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HG2' HE22 ' A' ' 49' ' ' GLN . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.454 HE22 ' HG2' ' A' ' 47' ' ' ARG . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD21 ' A' ' 50' ' ' LEU . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 7' ' ' LEU . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 42.3 t-80 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 . . . . . 0 CA--C 1.468 -2.207 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.432 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.681 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.582 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' CG1' ' HD3' ' A' ' 32' ' ' LYS . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 HD21 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.566 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.475 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 79' ' ' ILE . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HD11 ' A' ' 68' ' ' LEU . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.576 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.569 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.593 HG22 HD23 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.569 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 50' ' ' LEU . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 42.2 t-80 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.576 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 45.1 tt0 . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.44 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 79' ' ' ILE . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' CD1' HD21 ' A' ' 68' ' ' LEU . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' HE22 ' A' ' 49' ' ' GLN . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 50' ' ' LEU . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.644 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.686 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 7' ' ' LEU . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB2' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' LEU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.647 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 73' ' ' VAL . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' HB2' HD21 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 23' ' ' PRO . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.56 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' A' ' 8' ' ' GLU 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 48' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 12' ' ' ASN . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' H ' HG22 ' A' ' 11' ' ' THR . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 3' ' ' GLU . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 42' ' ' THR . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 41' ' ' THR . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 28' ' ' LEU . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 77' ' ' TYR . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD23 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD13 HD23 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' CD2' HD21 ' A' ' 50' ' ' LEU . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 7' ' ' LEU . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 45.0 t-80 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.8 t . . . . . 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.3 m -87.88 135.98 33.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.48 126.26 43.97 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB2' ' OD1' ' A' ' 88' ' ' ASN . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 68' ' ' LEU . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.426 HG12 HD22 ' A' ' 7' ' ' LEU . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -67.24 -30.97 71.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.75 79.89 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.754 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.87 72.46 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 114.214 0.445 . . . . 0.0 114.214 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 12' ' ' ASN . 26.0 t-20 -73.6 124.06 25.2 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.863 0.465 . . . . 0.0 111.929 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.58 3.33 0.65 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.709 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -86.09 113.4 22.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 -133.49 134.27 43.28 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.454 ' CG1' HD23 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 89' ' ' GLU . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB3' HD21 ' A' ' 88' ' ' ASN . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p -69.04 -26.67 65.09 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.24 80.43 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.382 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.57 29.19 74.37 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.319 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 83' ' ' ASP . 5.7 p30 -96.41 135.59 38.08 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 122.612 -0.346 . . . . 0.0 110.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' HB2' HG21 ' A' ' 82' ' ' VAL . 15.2 mm-40 65.25 13.05 8.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.862 1.265 . . . . 0.0 110.383 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.82 -179.252 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.0 m -87.19 113.2 22.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -160.15 139.44 10.91 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' LYS . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.611 HG22 HD22 ' A' ' 12' ' ' ASN . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.611 HD22 HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 4' ' ' VAL . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' OD1' ' HA3' ' A' ' 64' ' ' GLY . 29.3 m120 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.579 ' H ' HG22 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HE2' ' A' ' 66' ' ' LYS . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 50' ' ' LEU . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 10' ' ' THR . 35.7 t-80 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.27 -31.73 62.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.08 71.88 Favored Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.674 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.63 42.98 45.43 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.733 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.14 126.94 31.77 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 62.86 21.52 12.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.911 0.884 . . . . 0.0 110.776 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.566 -178.211 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mtp . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p -75.65 111.7 11.25 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -157.77 121.12 4.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 82' ' ' VAL . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.549 ' HE2' ' H ' ' A' ' 27' ' ' SER . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.549 ' H ' ' HE2' ' A' ' 26' ' ' MET . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 79' ' ' ILE . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD12 HG22 ' A' ' 73' ' ' VAL . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.677 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' HB2' ' A' ' 7' ' ' LEU . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 89' ' ' GLU . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -32.04 73.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.07 2.09 85.23 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.28 20.79 73.6 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-O 121.406 0.448 . . . . 0.0 112.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.07 137.37 36.24 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.137 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB2' HG21 ' A' ' 82' ' ' VAL . 8.7 mm-40 60.77 31.62 20.1 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 109.773 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.437 -1.121 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -178.076 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.5 p -68.41 112.92 5.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 33.8 mt-10 -136.73 100.68 4.39 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.456 HG23 ' HG1' ' A' ' 85' ' ' THR . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.639 HG22 HD23 ' A' ' 61' ' ' LEU . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' HE22 ' A' ' 56' ' ' GLN . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 52' ' ' ASP 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HB2' HD22 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 48' ' ' ILE . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 HD23 ' A' ' 7' ' ' LEU . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ASN . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HG1' HG23 ' A' ' 41' ' ' THR . 5.2 m -68.33 -32.74 73.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.6 15.69 34.76 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.794 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.96 47.47 90.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 91.1 m-20 -93.07 142.52 27.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.055 0.142 . . . . 0.0 111.114 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 64.5 19.66 11.88 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.905 0.882 . . . . 0.0 112.185 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.622 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.687 0.28 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -72.59 113.02 9.17 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.584 0.706 . . . . 0.0 109.229 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 -149.23 137.87 21.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.504 ' HB2' ' N ' ' A' ' 75' ' ' ASP . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.657 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.638 HG22 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 32' ' ' LYS . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.657 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG13 ' HD3' ' A' ' 32' ' ' LYS . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' CB ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB2' HD21 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 26' ' ' MET . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.454 ' HB3' HD21 ' A' ' 50' ' ' LEU . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m -76.53 -35.54 58.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.64 -4.31 30.19 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 84' ' ' VAL . . . 64.85 65.53 2.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.797 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -93.38 160.24 14.9 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.363 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 66.09 71.92 0.4 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.592 1.187 . . . . 0.0 108.529 -171.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 C--N 1.296 -1.742 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.753 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.241 0.62 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.4 t -94.91 112.11 23.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.32 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.19 133.46 31.41 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.152 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB3' HG23 ' A' ' 82' ' ' VAL . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.575 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.537 HG13 HD13 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' NE2' HD11 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.459 ' N ' HD23 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.571 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.524 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.693 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CD2' HD21 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -66.24 -24.9 66.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.03 -5.07 81.18 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.54 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.57 -9.34 8.22 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 113.755 0.262 . . . . 0.0 113.755 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -99.61 147.72 25.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 122.29 0.236 . . . . 0.0 110.802 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HB2' HG21 ' A' ' 82' ' ' VAL . 11.7 mm-40 62.61 24.68 14.7 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.179 0.924 . . . . 0.0 111.821 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.033 -179.013 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.2 m -91.92 112.95 25.08 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 24' ' ' ALA . 35.1 tt0 -145.33 92.86 2.3 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 6' ' ' ASP . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.527 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' HE2' ' A' ' 26' ' ' MET . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 32' ' ' LYS . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.681 ' H ' ' HG ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.648 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD13 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m -79.64 -34.46 40.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.25 -0.56 33.31 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.31 70.37 1.09 Allowed Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.325 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.21 143.36 27.37 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.273 -0.545 . . . . 0.0 109.781 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 63.9 92.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.37 1.044 . . . . 0.0 111.724 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.207 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.4 p -84.04 113.91 21.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.1 0.476 . . . . 0.0 110.182 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 -159.93 158.82 31.45 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 79' ' ' ILE . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' OE2' HG22 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' HG13 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 HE22 HG11 ' A' ' 82' ' ' VAL . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 57' ' ' LEU . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.585 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' GLY . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 7' ' ' LEU . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.522 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -65.38 -31.83 73.15 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.44 7.65 80.06 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.696 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 38.49 93.34 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -83.14 130.6 35.12 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.424 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.459 ' HG2' HG21 ' A' ' 82' ' ' VAL 0.349 11.6 pt-20 60.45 -34.74 0.08 Allowed 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 127.335 2.254 . . . . 0.0 116.949 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -99.56 136.85 38.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.333 0.396 . . . . 0.0 111.162 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 -115.9 136.25 53.22 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' HB3' HG23 ' A' ' 82' ' ' VAL . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 11' ' ' THR . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.738 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 32' ' ' LYS . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 61' ' ' LEU . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.738 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 50' ' ' LEU . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 48' ' ' ILE . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' THR . 77.3 t60 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 11' ' ' THR . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m -66.47 -32.1 73.26 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.04 1.6 74.28 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.649 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.58 31.64 80.54 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.23 148.42 39.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 71.33 69.44 0.17 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.324 1.449 . . . . 0.0 112.05 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 113.096 -1.866 . . . . 0.0 106.309 178.558 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 CA--C 1.494 -1.173 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -75.46 112.93 12.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 40.9 tt0 -100.54 67.12 1.28 Allowed 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 -168.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 14' ' ' THR . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 89' ' ' GLU . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.445 ' HA ' ' HE3' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 26' ' ' MET . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.609 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 82' ' ' VAL . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.412 ' H ' ' H ' ' A' ' 55' ' ' ASP . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 61' ' ' LEU 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' HD21 ' A' ' 71' ' ' LEU . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 63' ' ' ASP . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.599 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -84.51 -31.75 24.3 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.9 -1.69 56.15 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.04 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.8 -136.13 35.7 Favored Glycine 0 C--O 1.212 -1.273 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 88' ' ' ASN . 10.4 m120 -99.01 121.72 41.33 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.364 1.082 . . . . 0.0 111.9 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 13' ' ' ALA . 43.8 mt-10 52.49 85.2 0.05 OUTLIER 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.023 1.329 . . . . 0.0 113.771 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.266 177.641 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -94.22 112.81 24.64 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 -135.96 143.94 45.14 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG22 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 HD21 ' A' ' 61' ' ' LEU . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB2' HD22 ' A' ' 61' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 m -71.9 -33.47 68.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.17 9.37 54.24 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.32 39.69 98.07 Favored Glycine 0 CA--C 1.5 -0.858 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.53 123.44 34.94 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.086 0.469 . . . . 0.0 111.309 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.41 12.0 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.764 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.388 178.753 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -97.93 116.66 30.59 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.824 0.821 . . . . 0.0 111.863 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -136.18 132.35 35.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.51 ' OH ' HD13 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.465 ' H ' ' HA2' ' A' ' 64' ' ' GLY . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG13 ' HD3' ' A' ' 32' ' ' LYS . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.543 ' CE ' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB2' HD22 ' A' ' 61' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 61' ' ' LEU 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 28' ' ' LEU . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD13 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG21 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 -35.05 13.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.46 -3.44 29.05 Favored Glycine 0 CA--C 1.474 -2.51 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 83' ' ' ASP . . . -93.68 141.3 15.47 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 114.144 -1.028 . . . . 0.0 111.419 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -100.88 144.97 29.19 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 120.915 0.388 . . . . 0.0 111.72 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.44 18.76 3.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 166.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 C--O 1.258 1.512 0 CA-C-N 111.925 -2.398 . . . . 0.0 107.99 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -78.55 113.7 16.81 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -117.65 133.76 55.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.48 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.447 HD13 ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 73' ' ' VAL . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.559 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 61' ' ' LEU . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 9' ' ' ILE . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.3 t -81.39 -32.07 32.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.84 -2.98 60.94 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.489 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.66 21.7 79.46 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.71 139.1 38.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.067 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 66.06 15.63 10.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.672 1.189 . . . . 0.0 111.79 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.284 -176.777 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.237 0.399 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -99.55 120.2 39.26 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.32 71.54 1.47 Allowed 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.533 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HG2' HE22 ' A' ' 49' ' ' GLN . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 HE22 ' HG2' ' A' ' 47' ' ' ARG . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD21 ' A' ' 50' ' ' LEU . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 7' ' ' LEU . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 42.3 t-80 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t -85.64 -32.09 22.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.73 -5.15 60.13 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.01 -167.42 21.94 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.7 -0.75 . . . . 0.0 114.032 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.85 128.66 45.93 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.959 0.409 . . . . 0.0 111.38 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.46 9.88 37.49 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.003 0.906 . . . . 0.0 110.411 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.872 178.062 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -88.25 113.15 23.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -169.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 -159.84 101.18 1.45 Allowed 'General case' 0 CA--C 1.468 -2.207 0 C-N-CA 127.303 2.241 . . . . 0.0 107.585 169.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' A' ' 88' ' ' ASN . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.432 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.681 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.582 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' CG1' ' HD3' ' A' ' 32' ' ' LYS . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 HD21 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.566 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t -66.36 -32.49 73.91 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.57 -2.74 40.58 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.3 39.75 65.79 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 114.733 -0.733 . . . . 0.0 112.117 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.476 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 37.0 m-80 -86.62 121.65 29.44 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.634 -177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.35 21.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.811 1.291 . . . . 0.0 108.177 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.304 -175.686 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 p -91.45 110.88 22.19 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 -151.16 106.52 3.34 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.477 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 79' ' ' ILE . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HD11 ' A' ' 68' ' ' LEU . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.576 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.569 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.593 HG22 HD23 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.569 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 50' ' ' LEU . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 82' ' ' VAL . 42.2 t-80 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.576 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -93.25 -32.64 14.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.8 -0.28 56.4 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.714 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.86 170.39 44.36 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -81.7 135.41 35.51 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.58 91.68 0.09 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.963 1.305 . . . . 0.0 112.979 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 172.908 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.5 m -76.9 111.92 12.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 45.1 tt0 -156.49 113.33 3.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.44 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 79' ' ' ILE . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' CD1' HD21 ' A' ' 68' ' ' LEU . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' HE22 ' A' ' 49' ' ' GLN . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 50' ' ' LEU . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.644 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.686 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 7' ' ' LEU . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p -65.26 -26.42 68.09 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.83 -4.19 79.33 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.251 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.29 47.4 89.93 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -92.82 126.69 38.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.658 -0.271 . . . . 0.0 110.708 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 41.87 53.45 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.326 1.45 . . . . 0.0 114.527 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.402 -2.865 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.111 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 p -87.01 112.61 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.329 0.585 . . . . 0.0 110.264 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 -160.55 93.13 1.0 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.562 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' LEU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.647 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 73' ' ' VAL . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' HB2' HD21 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 23' ' ' PRO . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' A' ' 8' ' ' GLU 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 48' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 12' ' ' ASN . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -73.9 -31.37 63.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.16 -4.07 72.03 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.574 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.26 171.37 9.6 Favored Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.287 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.562 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.8 t-20 -83.08 122.94 28.99 Favored 'General case' 0 N--CA 1.42 -1.964 0 O-C-N 122.171 -0.605 . . . . 0.0 110.148 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 50.4 81.47 0.06 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.957 -178.272 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 p -99.11 111.87 24.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.968 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 -111.84 150.03 30.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' H ' HG22 ' A' ' 11' ' ' THR . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 3' ' ' GLU . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 42' ' ' THR . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 41' ' ' THR . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 28' ' ' LEU . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 77' ' ' TYR . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD23 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD13 HD23 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' CD2' HD21 ' A' ' 50' ' ' LEU . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 7' ' ' LEU . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 45.0 t-80 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.8 t -84.91 -33.72 22.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.46 -0.0 32.78 Favored Glycine 0 CA--C 1.48 -2.153 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.69 38.35 87.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -85.19 130.84 34.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 67.33 84.39 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 O-C-N 124.059 0.849 . . . . 0.0 109.818 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.612 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 68' ' ' LEU . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.426 HG12 HD22 ' A' ' 7' ' ' LEU . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 . . . . . 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.454 ' CG1' HD23 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' LYS . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.611 HG22 HD22 ' A' ' 12' ' ' ASN . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.611 HD22 HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 4' ' ' VAL . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.565 ' ND2' ' HA3' ' A' ' 64' ' ' GLY . 63.6 m-80 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.579 ' H ' HG22 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HE2' ' A' ' 66' ' ' LYS . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 50' ' ' LEU . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 10' ' ' THR . 76.7 t60 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 82' ' ' VAL . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.549 ' HE2' ' H ' ' A' ' 27' ' ' SER . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.549 ' H ' ' HE2' ' A' ' 26' ' ' MET . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 79' ' ' ILE . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD12 HG22 ' A' ' 73' ' ' VAL . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.677 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' HB2' ' A' ' 7' ' ' LEU . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 12' ' ' ASN . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 33.8 mt-10 . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.456 HG23 ' HG1' ' A' ' 85' ' ' THR . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.639 HG22 HD23 ' A' ' 61' ' ' LEU . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' HE22 ' A' ' 56' ' ' GLN . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 52' ' ' ASP 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HB2' HD22 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 48' ' ' ILE . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 HD23 ' A' ' 7' ' ' LEU . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HG1' HG23 ' A' ' 41' ' ' THR . 5.2 m . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.504 ' HB2' ' N ' ' A' ' 75' ' ' ASP . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.657 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.638 HG22 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 32' ' ' LYS . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.657 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG13 ' HD3' ' A' ' 32' ' ' LYS . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' CB ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB2' HD21 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 26' ' ' MET . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.454 ' HB3' HD21 ' A' ' 50' ' ' LEU . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB3' HG23 ' A' ' 82' ' ' VAL . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.575 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.537 HG13 HD13 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' NE2' HD11 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.459 ' N ' HD23 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.571 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.524 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.693 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CD2' HD21 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 24' ' ' ALA . 35.1 tt0 . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 6' ' ' ASP . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' HE2' ' A' ' 26' ' ' MET . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 32' ' ' LYS . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.681 ' H ' ' HG ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.648 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD13 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 79' ' ' ILE . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' OE2' HG22 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' HG13 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 HE22 HG11 ' A' ' 82' ' ' VAL . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 57' ' ' LEU . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.585 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' GLY . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 7' ' ' LEU . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.522 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 . . . . . 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' HB3' HG23 ' A' ' 82' ' ' VAL . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 11' ' ' THR . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.738 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 32' ' ' LYS . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 61' ' ' LEU . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.738 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 50' ' ' LEU . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 48' ' ' ILE . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' THR . 77.3 t60 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 11' ' ' THR . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 40.9 tt0 . . . . . 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 14' ' ' THR . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 26' ' ' MET . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.609 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 82' ' ' VAL . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.412 ' H ' ' H ' ' A' ' 55' ' ' ASP . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 61' ' ' LEU 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' HD21 ' A' ' 71' ' ' LEU . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 63' ' ' ASP . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.599 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG22 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 HD21 ' A' ' 61' ' ' LEU . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB2' HD22 ' A' ' 61' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 m . . . . . 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.51 ' OH ' HD13 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.465 ' H ' ' HA2' ' A' ' 64' ' ' GLY . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG13 ' HD3' ' A' ' 32' ' ' LYS . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.543 ' CE ' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB2' HD22 ' A' ' 61' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 61' ' ' LEU 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 28' ' ' LEU . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD13 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG21 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.415 -2.196 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.447 HD13 ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 73' ' ' VAL . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.559 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 61' ' ' LEU . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 9' ' ' ILE . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.3 t . . . . . 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.533 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HG2' HE22 ' A' ' 49' ' ' GLN . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.454 HE22 ' HG2' ' A' ' 47' ' ' ARG . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD21 ' A' ' 50' ' ' LEU . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 7' ' ' LEU . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 47' ' ' ARG . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 . . . . . 0 CA--C 1.468 -2.207 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.432 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.681 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.582 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.401 ' CG1' ' HD3' ' A' ' 32' ' ' LYS . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.532 HE21 HD11 ' A' ' 57' ' ' LEU . 32.4 tp60 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 HD21 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.532 HD11 HE21 ' A' ' 49' ' ' GLN . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.566 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.475 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 . . . . . 0 CA--C 1.478 -1.813 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 79' ' ' ILE . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HD11 ' A' ' 68' ' ' LEU . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.576 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.569 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.593 HG22 HD23 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.569 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 50' ' ' LEU . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.508 ' HD2' ' OE1' ' A' ' 49' ' ' GLN . 82.1 t60 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.576 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 45.1 tt0 . . . . . 0 N--CA 1.429 -1.515 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.44 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 79' ' ' ILE . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' CD1' HD21 ' A' ' 68' ' ' LEU . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' HE22 ' A' ' 49' ' ' GLN . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 50' ' ' LEU . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.644 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.686 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 7' ' ' LEU . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB2' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' LEU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.647 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 73' ' ' VAL . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' HB2' HD21 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 23' ' ' PRO . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.56 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' A' ' 8' ' ' GLU 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 48' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 12' ' ' ASN . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' H ' HG22 ' A' ' 11' ' ' THR . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 3' ' ' GLU . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 42' ' ' THR . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 41' ' ' THR . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 28' ' ' LEU . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 77' ' ' TYR . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.414 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD23 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD13 HD23 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' CD2' HD21 ' A' ' 50' ' ' LEU . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 7' ' ' LEU . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 82.7 t60 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.8 t . . . . . 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.3 m -87.88 135.98 33.16 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.48 126.26 43.97 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.45 141.33 46.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.72 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -125.08 140.52 52.82 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.695 -177.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.4 t70 -98.17 131.03 44.88 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.5 HD11 ' CE2' ' A' ' 5' ' ' TYR . 81.1 mt -126.43 156.08 41.17 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.66 118.16 35.43 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.05 134.31 36.86 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -126.99 160.89 29.72 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.8 m -148.31 166.22 28.69 Favored 'General case' 0 C--N 1.268 -2.962 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB2' ' OD1' ' A' ' 88' ' ' ASN . 26.0 p-10 -85.09 -33.27 22.45 Favored 'General case' 0 C--N 1.249 -3.802 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.701 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.85 59.24 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.342 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 40.4 p -105.74 147.32 28.72 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.58 16.6 20.58 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.605 1.193 . . . . 0.0 108.801 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -116.57 111.68 41.53 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.223 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.45 136.42 36.63 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.613 2.209 . . . . 0.0 110.226 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -118.62 122.4 42.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.17 126.68 42.51 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.541 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -154.47 152.38 30.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.865 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 4.0 ttmp? -102.42 140.09 37.15 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -134.83 163.71 49.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.23 128.02 9.5 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.939 1.76 . . . . 0.0 111.316 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . . . -80.32 -13.08 59.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.715 0.769 . . . . 0.0 110.404 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.47 -8.71 86.72 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.289 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.9 tpt -90.56 170.87 9.81 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.785 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.7 p -83.46 156.91 22.65 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.317 0.647 . . . . 0.0 111.246 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 68' ' ' LEU . 58.8 tp -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.904 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -58.71 -30.17 67.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.326 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -76.37 -45.99 29.43 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.181 0.515 . . . . 0.0 110.214 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 3.3 tm? -57.61 -48.78 78.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.735 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 21.9 ptmt -70.31 -31.03 68.18 Favored 'General case' 0 C--O 1.18 -2.594 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.512 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -64.91 -33.99 77.35 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 118.756 0.707 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -62.34 -42.51 99.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 75.4 mt -70.19 -42.77 71.97 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.62 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 41.6 mt-10 -56.58 -32.39 65.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.854 1.262 . . . . 0.0 110.955 176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.9 tp -69.93 -37.47 75.91 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.25 0.547 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.86 -41.42 17.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -87.53 -27.15 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.82 2.87 80.92 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.219 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 12.3 m -79.82 171.39 15.19 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 43' ' ' VAL . 20.0 m -113.11 172.16 7.11 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' H ' HG22 ' A' ' 42' ' ' THR . 31.2 t -59.47 -48.65 86.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -168.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -80.01 -27.46 39.56 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.583 0.706 . . . . 0.0 111.188 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -84.84 -9.15 58.43 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.919 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.1 ttt -113.09 112.51 23.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HD2' ' CD ' ' A' ' 60' ' ' GLU . 11.4 tpp180 -101.58 138.94 37.9 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.11 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -112.28 121.89 65.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.687 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -111.87 138.77 48.03 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.88 122.19 46.69 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.571 0.7 . . . . 0.0 111.789 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.97 129.25 53.43 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' TYR . 17.9 t70 -70.05 168.58 15.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.289 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.48 76.43 Favored Glycine 0 C--N 1.274 -2.869 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.556 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.42 -58.53 3.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.525 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.5 t70 174.78 -52.39 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.849 0.718 . . . . 0.0 111.41 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -65.79 152.74 43.66 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 126.46 31.92 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.108 -1.405 . . . . 0.0 107.434 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 7.3 mmpt? -86.47 -43.82 12.48 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 110.103 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.07 -160.23 33.49 Favored Glycine 0 C--N 1.293 -1.845 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.693 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' HD2' ' A' ' 47' ' ' ARG . 32.9 tt0 -104.85 139.08 40.12 Favored 'General case' 0 N--CA 1.397 -3.103 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 62' ' ' THR . 89.1 mt -78.94 -94.04 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.287 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 97.5 m 79.46 -3.68 2.07 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.658 169.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' HD11 ' A' ' 71' ' ' LEU . 29.2 m-20 -106.68 108.78 20.46 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.73 14.09 27.11 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.88 -16.43 53.66 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.81 -178.36 3.6 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.03 157.4 15.91 Favored 'General case' 0 N--CA 1.405 -2.724 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 5' ' ' TYR . 34.9 mt -63.27 -25.72 68.45 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-O 121.677 0.751 . . . . 0.0 110.817 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -75.71 -43.36 47.48 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -68.23 -31.35 70.78 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.497 0.665 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 63' ' ' ASP . 94.3 mt -73.8 -13.71 60.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.725 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.2 44.2 94.24 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.66 -44.01 60.86 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 60.7 mtt180 63.22 175.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 125.117 1.367 . . . . 0.0 113.359 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.66 156.49 16.67 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.081 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.12 16.25 77.02 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.795 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 52' ' ' ASP . 7.7 m-85 -100.77 157.04 17.0 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.102 0.561 . . . . 0.0 111.443 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -112.22 121.28 44.48 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.426 HG12 HD22 ' A' ' 7' ' ' LEU . 40.6 mm -105.74 117.75 52.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.363 0.602 . . . . 0.0 109.955 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -104.4 121.54 43.61 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.866 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.33 141.9 35.13 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 9.1 p -132.92 133.53 58.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.84 120.52 29.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.97 -23.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.698 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -67.24 -30.97 71.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.059 0.457 . . . . 0.0 111.74 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.75 79.89 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.754 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.87 72.46 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 114.214 0.445 . . . . 0.0 114.214 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 12' ' ' ASN . 26.0 t-20 -73.6 124.06 25.2 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.863 0.465 . . . . 0.0 111.929 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.58 3.33 0.65 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.249 1.041 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.709 -179.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -86.09 113.4 22.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 46.2 mt-10 -133.49 134.27 43.28 Favored 'General case' 0 CA--C 1.47 -2.099 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.6 m -136.24 148.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -124.15 142.29 51.34 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.988 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -91.31 116.3 28.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 79' ' ' ILE . 6.4 mp -109.26 150.5 27.86 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 121.202 0.525 . . . . 0.0 110.837 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -110.14 122.58 47.95 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.8 mm -95.57 125.93 48.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -130.75 154.01 48.42 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.107 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -147.79 164.74 32.69 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -81.81 -30.53 32.17 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.76 -12.6 50.6 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.807 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.4 p -108.06 139.4 42.76 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -93.7 -31.85 14.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.86 0.362 . . . . 0.0 111.072 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -104.81 113.9 64.42 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.97 149.24 77.29 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 123.134 2.556 . . . . 0.0 111.578 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.5 mtt -119.96 132.11 55.4 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.01 129.09 46.03 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.964 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -145.88 147.78 32.14 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -94.6 136.59 34.73 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.81 149.06 71.89 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 24.5 Cg_exo -65.12 147.08 88.27 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 122.339 2.026 . . . . 0.0 112.317 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.25 67.55 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.0 111.872 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.8 6.53 76.97 Favored Glycine 0 C--N 1.305 -1.178 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.305 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.74 147.95 48.47 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 109.972 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 p -91.82 143.37 26.58 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.636 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.8 tm? -62.18 -32.74 73.4 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 94.2 m-20 -69.44 -40.22 77.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.52 -28.24 62.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.62 0.724 . . . . 0.0 109.056 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tt -73.83 -39.99 63.64 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.5 mtpt -59.06 -46.17 88.95 Favored 'General case' 0 C--O 1.173 -2.929 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 1.4 tppp? -58.72 -33.37 70.14 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.431 0.693 . . . . 0.0 110.082 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -73.81 -43.32 59.18 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 123.958 0.903 . . . . 0.0 110.19 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.5 mt -67.32 -34.86 78.24 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 33' ' ' LYS . 35.6 mt-10 -55.78 -34.02 64.89 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.591 1.157 . . . . 0.0 110.485 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.7 tp -75.4 -31.83 60.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.372 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.69 -41.72 14.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.464 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -89.48 -23.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.473 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.53 3.21 86.7 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.183 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 42' ' ' THR . 7.6 m -83.16 173.09 11.98 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 41' ' ' THR . 44.2 p -113.45 176.07 5.18 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.99 -47.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -78.3 -32.45 49.4 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.31 0.576 . . . . 0.0 111.201 -173.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 m -80.36 -10.74 59.75 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.801 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 ttt -105.07 112.76 26.01 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.625 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -108.09 141.86 39.16 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.4 mt -122.08 134.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -112.24 149.73 31.91 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.444 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 48.5 tp -116.43 131.9 56.82 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 82.0 m-85 -121.16 155.61 34.14 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' OD1' ' HE2' ' A' ' 58' ' ' LYS . 6.6 m-20 -67.8 -175.63 0.57 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.92 0.867 . . . . 0.0 111.605 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.36 1.15 Allowed Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -147.1 -65.06 0.28 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.159 -1.021 . . . . 0.0 109.408 -170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 t70 170.56 -47.16 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.336 1.054 . . . . 0.0 108.736 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -64.65 149.24 49.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.465 -1.698 . . . . 0.0 115.207 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.2 tp -83.75 133.33 34.79 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.385 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HE2' ' OD1' ' A' ' 52' ' ' ASP . 69.0 mmtt -84.7 -43.58 14.19 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.35 -165.17 34.28 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.45 122.54 45.11 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 62' ' ' THR . 88.7 mt -92.03 -125.64 0.09 Allowed 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.043 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 61' ' ' LEU 0.266 2.0 t 82.09 6.8 1.02 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.538 2.335 . . . . 0.0 111.371 178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 2.2 m-20 -60.74 -72.0 0.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.017 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 76.47 -18.1 3.82 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.138 -0.937 . . . . 0.0 114.934 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.66 41.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 122.064 0.935 . . . . 0.0 109.632 176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -122.16 155.53 35.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -85.89 173.44 9.98 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.58 -32.32 73.75 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.118 0.485 . . . . 0.0 110.292 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -69.79 -43.18 72.65 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.719 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.28 -30.98 62.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.733 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -74.43 -13.32 60.7 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.354 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.99 27.01 29.82 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.005 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.6 t -93.11 138.95 18.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 69.7 mtt180 -138.87 -177.61 4.95 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.11 141.52 49.16 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 121.337 0.589 . . . . 0.0 110.582 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.27 -13.99 63.61 Favored Glycine 0 C--N 1.279 -2.592 0 CA-C-N 114.516 -1.22 . . . . 0.0 112.31 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m-85 -76.12 145.37 40.05 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.051 0.453 . . . . 0.0 110.121 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 51' ' ' PHE . 39.3 ptt180 -108.13 138.4 44.46 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.631 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.454 ' CG1' HD23 ' A' ' 7' ' ' LEU . 42.0 mm -100.79 126.15 54.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -109.96 121.09 44.44 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 120.849 0.357 . . . . 0.0 110.919 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.61 141.79 31.94 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 89' ' ' GLU . 10.6 p -138.19 149.48 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.268 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB3' HD21 ' A' ' 88' ' ' ASN . 15.5 t70 -97.85 125.45 42.72 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.199 0.523 . . . . 0.0 109.977 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.96 -33.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.6 p -69.04 -26.67 65.09 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.49 -4.24 80.43 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.382 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.57 29.19 74.37 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.319 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 83' ' ' ASP . 5.7 p30 -96.41 135.59 38.08 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 122.612 -0.346 . . . . 0.0 110.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' HB2' HG21 ' A' ' 82' ' ' VAL . 15.2 mm-40 65.25 13.05 8.51 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.862 1.265 . . . . 0.0 110.383 -176.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.303 -1.421 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.82 -179.252 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.0 m -87.19 113.2 22.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -160.15 139.44 10.91 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' LYS . 18.4 m -140.03 156.22 24.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.98 139.55 53.72 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.564 1.146 . . . . 0.0 109.374 174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -86.42 118.78 26.07 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 79' ' ' ILE . 83.3 mt -118.31 155.84 29.93 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.007 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 44.9 tt0 -109.48 123.54 49.56 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.8 mm -95.97 131.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 121.405 0.622 . . . . 0.0 110.234 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 20.1 p -133.3 149.41 51.93 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.13 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.611 HG22 HD22 ' A' ' 12' ' ' ASN . 2.8 m -150.9 155.91 40.11 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.611 HD22 HG22 ' A' ' 11' ' ' THR . 0.1 OUTLIER -72.33 -15.41 61.88 Favored 'General case' 0 C--N 1.254 -3.563 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.207 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.58 -2.3 20.43 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.284 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 p -117.46 142.39 47.21 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -92.01 -44.21 8.99 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 90.2 t80 -84.99 119.17 72.28 Favored Pre-proline 0 C--N 1.303 -1.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.694 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 5.4 Cg_exo -78.68 129.45 9.2 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.079 2.519 . . . . 0.0 109.393 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.1 ttt -126.94 136.96 53.0 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.68 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.71 124.53 34.2 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 121.398 0.618 . . . . 0.0 109.373 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HD3' ' OH ' ' A' ' 22' ' ' TYR . 88.2 tttt -138.4 146.17 41.89 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.827 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HD2' HG21 ' A' ' 4' ' ' VAL . 38.8 ttpt -95.01 129.51 42.05 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 122.857 0.463 . . . . 0.0 111.12 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 20' ' ' LYS . 96.7 m-85 -130.64 151.24 78.39 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 122.723 0.409 . . . . 0.0 110.542 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.37 140.55 40.63 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.446 2.097 . . . . 0.0 113.211 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.13 -42.65 93.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.287 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.87 -2.47 90.25 Favored Glycine 0 C--N 1.289 -2.048 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.604 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.6 ttp -73.53 150.98 41.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.905 0.353 . . . . 0.0 110.251 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 p -82.98 151.99 25.63 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.78 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.612 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 tm? -61.87 -29.55 70.27 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.565 ' ND2' ' HA3' ' A' ' 64' ' ' GLY . 63.6 m-80 -62.03 -42.59 99.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.545 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -73.3 -28.89 62.35 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.3 tm? -62.02 -48.43 80.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.4 mtpt -60.21 -50.45 73.63 Favored 'General case' 0 C--O 1.179 -2.608 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.524 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -59.62 -28.71 67.44 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.38 65.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.33 -46.96 81.21 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.402 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 36' ' ' GLU . 4.2 mm-40 -59.14 -30.66 68.31 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 125.033 1.333 . . . . 0.0 112.844 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.0 tp -65.68 -31.96 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.316 0.579 . . . . 0.0 109.684 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.3 t -89.27 -41.9 14.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.611 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 t -80.8 -28.43 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.74 4.69 90.29 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.659 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 42' ' ' THR . 20.9 m -81.36 -179.25 7.29 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.579 ' H ' HG22 ' A' ' 41' ' ' THR . 33.5 p -109.01 146.75 33.41 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 122.795 0.438 . . . . 0.0 110.76 176.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.69 -41.3 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.754 0.822 . . . . 0.0 112.69 -170.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.33 -28.01 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.22 0.533 . . . . 0.0 112.051 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.9 m -95.75 1.43 53.33 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.9 tpt -120.48 125.89 49.02 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.081 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -117.02 143.58 45.57 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 79' ' ' ILE . 1.8 mp -110.62 130.0 64.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.709 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -113.8 150.07 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.391 0.676 . . . . 0.0 109.231 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.8 tt -113.74 124.68 52.86 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.34 148.11 33.69 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.63 -173.13 4.35 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 121.267 0.556 . . . . 0.0 111.626 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.46 88.9 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.327 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.55 -66.13 0.95 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 175.51 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.884 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.23 148.55 47.83 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.9 tt -84.57 118.82 24.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.919 -1.491 . . . . 0.0 107.288 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 58' ' ' LYS . 38.5 mmtm -83.92 -34.53 24.48 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.84 165.82 35.66 Favored Glycine 0 C--N 1.287 -2.192 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.349 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -106.59 119.76 40.15 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 mm? -87.61 -148.23 0.15 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.242 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 t 104.26 -2.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.847 2.459 . . . . 0.0 109.411 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 105.41 13.78 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . -107.3 0.45 35.1 Favored Glycine 0 C--N 1.288 -2.124 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.603 -175.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.79 -12.28 61.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.963 0.887 . . . . 0.0 109.418 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.631 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.0 ptmt -122.68 150.03 43.25 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.391 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.4 p -81.23 174.25 11.72 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 120.946 0.403 . . . . 0.0 111.732 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 82.2 mt -62.42 -34.13 76.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.013 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -70.0 -38.13 75.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.295 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 16.8 t70 -78.13 -30.27 49.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.556 0.693 . . . . 0.0 109.571 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HE2' ' A' ' 66' ' ' LYS . 67.9 mt -73.65 -13.19 60.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.212 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.51 59.63 Favored Glycine 0 C--N 1.315 -0.613 0 C-N-CA 120.153 -1.022 . . . . 0.0 111.692 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 50' ' ' LEU . 39.8 t -87.05 96.41 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -116.79 -172.82 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.036 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.24 137.29 58.15 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.735 0.779 . . . . 0.0 111.475 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.27 -5.26 83.79 Favored Glycine 0 C--N 1.268 -3.24 0 CA-C-N 114.307 -1.315 . . . . 0.0 114.872 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -78.34 153.0 32.06 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 117.706 0.753 . . . . 0.0 112.118 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -105.68 121.85 44.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.085 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' A' ' 7' ' ' LEU . 1.7 mp -105.23 123.62 59.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 10' ' ' THR . 76.7 t60 -115.42 130.1 56.78 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.116 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.89 140.77 47.41 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.74 145.87 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 122.5 0.32 . . . . 0.0 110.257 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.58 129.52 34.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.562 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.34 -26.68 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.022 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.27 -31.73 62.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.499 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.2 -4.08 71.88 Favored Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.674 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.63 42.98 45.43 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.733 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.14 126.94 31.77 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 62.86 21.52 12.88 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.911 0.884 . . . . 0.0 110.776 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.307 -1.281 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.566 -178.211 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mtp . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 p -75.65 111.7 11.25 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -157.77 121.12 4.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 25.5 m -139.0 148.05 24.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 123.569 0.747 . . . . 0.0 109.963 -174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -124.85 129.04 49.64 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.235 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.6 116.87 23.4 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -122.01 156.49 33.37 Favored 'General case' 0 C--N 1.256 -3.487 0 C-N-CA 122.661 0.384 . . . . 0.0 111.706 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.46 119.6 39.99 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.74 132.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.388 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.8 p -126.66 159.13 34.53 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.384 -1.28 . . . . 0.0 108.596 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 m -151.29 167.78 26.79 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 82' ' ' VAL . 22.1 p-10 -71.42 -27.24 63.15 Favored 'General case' 0 C--N 1.261 -3.261 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.65 -15.97 35.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.848 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.9 p -117.44 128.56 55.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.98 -18.63 20.11 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.094 0.949 . . . . 0.0 108.49 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.44 126.88 52.94 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.468 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.99 142.26 12.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.438 2.092 . . . . 0.0 111.894 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.53 122.91 26.92 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.94 141.38 31.29 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.41 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -135.57 150.84 49.82 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 124.674 1.19 . . . . 0.0 107.994 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.42 129.38 56.56 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.356 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -136.23 150.18 70.17 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 38.0 Cg_exo -61.46 143.66 97.56 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.314 2.009 . . . . 0.0 111.249 176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -64.65 -27.78 69.16 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.919 0.866 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.27 7.41 82.11 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.529 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.549 ' HE2' ' H ' ' A' ' 27' ' ' SER . 1.5 tpt -87.26 153.84 21.17 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.549 ' H ' ' HE2' ' A' ' 26' ' ' MET . 29.7 p -83.2 146.3 28.68 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 123.407 0.683 . . . . 0.0 110.102 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tt -69.18 -22.23 63.92 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HB2' ' HA3' ' A' ' 64' ' ' GLY . 5.9 t-20 -56.0 -44.57 78.75 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.242 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.46 -36.72 74.08 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.734 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 tm? -61.07 -48.4 81.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.301 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 48.1 mtpt -63.53 -42.46 98.43 Favored 'General case' 0 C--O 1.169 -3.168 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.386 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.76 -35.81 71.25 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.156 0.582 . . . . 0.0 110.433 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -67.81 -44.34 77.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.84 -46.57 84.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.432 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -59.28 -31.6 69.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.788 1.235 . . . . 0.0 111.588 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.3 tp -69.5 -32.44 71.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.367 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.9 t -88.74 -42.0 14.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.365 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 t -83.47 -26.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.93 0.395 . . . . 0.0 111.308 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.94 9.61 85.12 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 42' ' ' THR . 5.3 m -77.41 175.18 10.03 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.5 ' H ' HG22 ' A' ' 41' ' ' THR . 33.6 p -111.79 144.08 41.69 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.41 -36.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -167.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.91 -39.47 90.6 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -87.45 1.38 53.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.458 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -113.77 119.37 37.11 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -101.97 144.32 30.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 79' ' ' ILE . 47.6 mm -115.63 119.39 61.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 54.4 mt-30 -113.45 148.65 35.51 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.168 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD12 HG22 ' A' ' 73' ' ' VAL . 5.8 tt -116.37 125.22 51.78 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.452 0.644 . . . . 0.0 111.091 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 89.2 m-85 -115.53 149.63 37.86 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.64 -169.89 2.37 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.383 0.611 . . . . 0.0 111.267 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.57 -29.96 74.47 Favored Glycine 0 C--N 1.309 -0.935 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.211 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.73 -66.15 0.92 Allowed 'General case' 0 C--O 1.247 0.968 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -174.89 -46.32 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -58.75 139.84 55.68 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.4 tp -74.3 119.73 18.89 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 113.328 -1.76 . . . . 0.0 108.475 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -83.71 -43.14 15.83 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.73 -168.8 41.63 Favored Glycine 0 N--CA 1.418 -2.521 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.002 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.4 tt0 -112.9 134.61 54.33 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.591 ' O ' HG22 ' A' ' 62' ' ' THR . 94.9 mt -104.61 -95.96 0.33 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 61' ' ' LEU 0.31 4.2 t 79.69 -2.93 2.08 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 127.661 2.384 . . . . 0.0 112.569 174.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -79.01 130.32 35.4 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 29' ' ' ASN . . . -123.12 8.22 9.13 Favored Glycine 0 C--N 1.298 -1.583 0 C-N-CA 119.67 -1.253 . . . . 0.0 113.265 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.9 -7.32 59.46 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.49 159.69 17.29 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.159 178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 m -88.49 166.86 13.91 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.6 -34.65 73.02 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.532 0.682 . . . . 0.0 109.227 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 28.4 tptp -74.3 -36.61 63.75 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.866 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.08 -34.46 76.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.612 0.72 . . . . 0.0 109.068 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.31 -13.33 59.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.709 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.84 28.99 22.16 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.838 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG22 HD12 ' A' ' 50' ' ' LEU . 48.5 t -89.62 137.88 20.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.677 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 95.6 mtt180 -128.43 -176.77 3.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -82.93 145.55 29.33 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.512 0.672 . . . . 0.0 111.242 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.04 11.91 77.84 Favored Glycine 0 C--N 1.289 -2.063 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.232 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.677 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 8.3 m-85 -99.61 156.17 17.21 Favored 'General case' 0 CA--C 1.501 -0.942 0 O-C-N 122.519 -0.401 . . . . 0.0 110.728 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 64.9 mtt180 -105.42 121.5 44.04 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 111.159 -175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.496 HD13 ' HB2' ' A' ' 7' ' ' LEU . 1.8 mp -106.25 116.05 49.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.519 177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -100.84 121.49 41.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.133 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.42 137.84 40.97 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 89' ' ' GLU . 9.2 p -147.12 133.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -78.88 131.56 36.46 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.883 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.51 -11.0 8.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-O 121.428 0.632 . . . . 0.0 109.704 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -32.04 73.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.379 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.07 2.09 85.23 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.28 20.79 73.6 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-O 121.406 0.448 . . . . 0.0 112.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -97.07 137.37 36.24 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.137 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB2' HG21 ' A' ' 82' ' ' VAL . 8.7 mm-40 60.77 31.62 20.1 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 109.773 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.437 -1.121 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -178.076 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.5 p -68.41 112.92 5.55 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 33.8 mt-10 -136.73 100.68 4.39 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.968 0.889 . . . . 0.0 110.787 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 130.03 27.83 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.454 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 50.6 m-85 -109.64 141.35 42.31 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.12 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.72 115.11 27.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 79' ' ' ILE . 7.1 mp -104.39 142.03 35.3 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.396 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -110.85 114.63 28.12 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.1 mp -105.74 130.11 57.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.505 -172.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 21.0 p -116.28 150.06 38.22 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.088 173.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 10.4 p -135.2 167.59 20.72 Favored 'General case' 1 N--CA 1.374 -4.249 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -78.62 -22.11 47.47 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.25 50.27 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.44 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.6 p -120.35 127.03 51.95 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -97.0 5.95 49.52 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.479 1.133 . . . . 0.0 109.439 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.8 m-85 -87.33 143.69 34.77 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.133 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 12.8 Cg_exo -68.82 125.33 12.49 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.279 1.986 . . . . 0.0 111.142 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.87 121.74 36.93 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 11.6 pt-20 -113.99 134.83 54.59 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.377 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HD3' ' N ' ' A' ' 21' ' ' LYS . 8.9 tmtt? -146.53 138.18 24.6 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.561 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 36.8 ttpt -97.13 125.77 41.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.612 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.87 152.94 70.63 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.53 144.93 86.45 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.538 2.159 . . . . 0.0 112.44 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -59.37 -33.56 71.33 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.984 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.55 9.62 76.7 Favored Glycine 0 C--N 1.292 -1.879 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.976 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 tpt -80.49 158.12 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.193 0.997 . . . . 0.0 109.664 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 6.6 m -83.59 141.71 31.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.1 tm? -64.99 -32.5 74.26 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.0 m-20 -64.4 -34.02 77.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.177 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.31 -31.65 65.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.944 0.878 . . . . 0.0 108.757 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 tm? -64.49 -48.92 73.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.408 -1.269 . . . . 0.0 107.825 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.1 mtpt -60.95 -42.62 98.62 Favored 'General case' 0 C--O 1.18 -2.599 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.871 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -59.76 -35.23 74.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 122.973 0.509 . . . . 0.0 111.625 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -36.1 70.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -69.74 -42.86 73.38 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.282 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -56.32 -38.52 71.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.32 -34.08 76.61 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.386 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.13 -41.56 14.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.879 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.9 t -92.65 -15.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.085 0.469 . . . . 0.0 111.482 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.41 90.52 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.973 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.456 HG23 ' HG1' ' A' ' 85' ' ' THR . 11.3 m -70.51 169.49 14.03 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.61 0.764 . . . . 0.0 110.587 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.1 m -115.38 171.51 7.67 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 42' ' ' THR . 44.6 t -63.08 -49.01 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.15 -27.88 42.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.58 0.705 . . . . 0.0 110.241 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 84' ' ' VAL . 21.8 m -80.12 -0.4 35.7 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.612 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.462 ' SD ' HD11 ' A' ' 48' ' ' ILE . 52.3 ttm -111.89 112.18 23.66 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.954 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -98.87 130.33 45.27 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.639 HG22 HD23 ' A' ' 61' ' ' LEU . 44.1 mt -126.03 134.6 66.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.559 -175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.47 139.39 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.751 0.821 . . . . 0.0 110.46 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 61' ' ' LEU . 6.2 tt -108.84 114.33 28.02 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 121.249 0.547 . . . . 0.0 110.738 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.13 125.47 51.12 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' HE22 ' A' ' 56' ' ' GLN . 17.2 t70 -55.59 -57.35 12.31 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.982 0.896 . . . . 0.0 109.398 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.6 -67.19 0.1 Allowed Glycine 0 C--N 1.28 -2.577 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.369 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -157.48 154.03 28.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 73.19 -64.17 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.957 1.303 . . . . 0.0 114.106 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 52' ' ' ASP 0.283 2.7 pp0? -86.3 132.29 34.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -175.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' LEU . 39.4 tp -83.55 131.4 34.99 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.414 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HB2' HD22 ' A' ' 50' ' ' LEU . 73.2 mmtt -93.06 -43.0 9.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.456 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.88 -177.13 38.45 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -123.19 141.4 52.01 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 48' ' ' ILE . 2.4 mm? -81.95 -151.46 0.09 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.625 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 61' ' ' LEU 0.37 0.9 OUTLIER 95.87 -2.71 0.07 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.178 0.989 . . . . 0.0 113.373 -178.268 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 5.3 m-20 -100.62 107.72 19.44 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -114.91 8.57 21.46 Favored Glycine 0 CA--C 1.474 -2.519 0 C-N-CA 119.162 -1.494 . . . . 0.0 113.87 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.15 -16.82 48.5 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 9.8 mptt -95.1 164.54 12.83 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 175.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -91.5 174.48 7.35 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 120.91 0.385 . . . . 0.0 110.106 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.78 -36.36 82.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.052 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.6 tttt -69.59 -42.16 74.82 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.642 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.16 -36.37 79.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.311 0.576 . . . . 0.0 110.261 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 63' ' ' ASP . 85.8 mt -74.17 -13.25 60.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.003 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.77 20.57 43.14 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.346 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.06 106.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.449 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 82.2 mtm180 -107.44 -173.63 2.34 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.94 144.55 45.23 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.559 0.695 . . . . 0.0 110.684 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.34 2.43 87.6 Favored Glycine 0 C--N 1.277 -2.719 0 CA-C-N 114.273 -1.331 . . . . 0.0 113.086 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 6.9 m-85 -82.15 151.75 26.8 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.851 0.358 . . . . 0.0 111.549 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 95.4 mtt180 -104.94 123.12 47.21 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.725 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG13 HD23 ' A' ' 7' ' ' LEU . 48.1 mm -111.07 114.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 81.0 t60 -106.87 117.42 34.01 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.393 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -107.06 137.68 44.67 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 120.865 0.364 . . . . 0.0 110.058 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.71 134.87 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-O 121.271 0.558 . . . . 0.0 109.743 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ASN . 11.5 t70 -88.58 116.41 26.8 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.703 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 45' ' ' SER . 7.3 p -107.55 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HG1' HG23 ' A' ' 41' ' ' THR . 5.2 m -68.33 -32.74 73.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.6 15.69 34.76 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.794 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.96 47.47 90.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 91.1 m-20 -93.07 142.52 27.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.055 0.142 . . . . 0.0 111.114 -176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 64.5 19.66 11.88 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.905 0.882 . . . . 0.0 112.185 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.622 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.687 0.28 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -72.59 113.02 9.17 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.584 0.706 . . . . 0.0 109.229 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 33.6 tt0 -149.23 137.87 21.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.7 m -134.2 140.45 46.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.122 0.487 . . . . 0.0 110.079 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.504 ' HB2' ' N ' ' A' ' 75' ' ' ASP . 22.6 p90 -125.36 142.64 51.39 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.13 131.52 35.23 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.4 mp -123.05 152.8 40.65 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 40.0 tt0 -110.86 120.36 42.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 167.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 44.2 mm -95.68 130.6 44.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 47.6 p -123.3 149.96 44.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.956 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.1 m -136.42 166.26 23.9 Favored 'General case' 0 C--N 1.262 -3.224 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -84.56 -24.38 29.29 Favored 'General case' 0 C--N 1.261 -3.242 0 CA-C-O 121.738 0.78 . . . . 0.0 108.929 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.0 -12.78 49.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.987 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.2 p -114.32 139.57 49.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.863 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.26 -40.64 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.65 117.38 68.61 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.037 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.31 147.41 78.11 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 122.374 2.049 . . . . 0.0 109.043 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ttt -124.72 122.59 37.9 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.958 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -78.06 139.4 39.08 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 120.527 0.204 . . . . 0.0 110.859 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -144.61 156.11 43.96 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 123.465 0.706 . . . . 0.0 112.549 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.11 117.1 30.3 Favored 'General case' 0 N--CA 1.424 -1.752 0 C-N-CA 124.772 1.229 . . . . 0.0 109.229 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 69.4 m-85 -125.52 145.99 53.1 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 16.6 Cg_exo -70.84 137.56 32.55 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.491 2.127 . . . . 0.0 111.143 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.31 -19.96 64.72 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.698 0.761 . . . . 0.0 111.064 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.16 1.62 87.63 Favored Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 52.6 ttm -83.96 156.73 22.17 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 122.725 -0.28 . . . . 0.0 110.435 177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' MET . 58.3 p -83.41 155.12 23.63 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -59.66 -33.07 71.07 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -60.51 -39.85 89.27 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.88 -34.03 62.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 tt -67.25 -45.22 77.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.657 ' NZ ' ' HB3' ' A' ' 46' ' ' MET . 25.5 mmmt -55.09 -52.71 62.37 Favored 'General case' 0 C--O 1.16 -3.628 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.822 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.86 -24.79 66.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.151 0.5 . . . . 0.0 111.37 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.29 -41.14 41.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.62 -51.37 43.04 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.104 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 48.2 mm-40 -55.6 -30.81 61.53 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.541 1.536 . . . . 0.0 111.39 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.0 tp -61.35 -38.63 87.64 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.21 -33.98 6.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.234 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 41' ' ' THR . 58.2 t -80.25 -27.83 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.84 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.75 13.1 74.95 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.948 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.638 HG22 ' H ' ' A' ' 42' ' ' THR . 26.6 m -103.67 -174.18 2.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 41' ' ' THR . 7.0 p -109.69 157.42 19.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 117.981 0.355 . . . . 0.0 111.238 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 32' ' ' LYS . 97.0 t -59.18 -46.35 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -171.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.34 -35.96 68.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.981 0.419 . . . . 0.0 112.069 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 40.9 m -87.75 1.1 54.71 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.657 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 12.5 tpt -119.43 113.76 21.27 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -92.72 141.92 27.92 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG13 ' HD3' ' A' ' 32' ' ' LYS . 48.7 mm -115.38 119.89 63.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.017 0.437 . . . . 0.0 111.685 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.38 156.14 23.97 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD22 ' CB ' ' A' ' 58' ' ' LYS . 2.7 tt -117.4 122.09 42.86 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.61 141.58 50.2 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -80.26 -172.64 3.6 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.343 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.04 -23.32 59.28 Favored Glycine 0 C--N 1.312 -0.803 0 CA-C-N 115.218 -0.901 . . . . 0.0 114.27 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.07 -72.5 0.51 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 117.509 0.654 . . . . 0.0 111.959 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -178.44 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 O-C-N 123.307 0.38 . . . . 0.0 110.564 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -53.73 149.51 8.38 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.913 0.863 . . . . 0.0 113.0 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 tp -80.67 118.81 22.56 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.724 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' CB ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -83.75 -42.46 16.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -170.09 42.22 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.63 139.0 54.43 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 6.6 mp -72.19 -86.0 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.378 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.0 m 80.59 -3.53 1.85 Allowed 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.394 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB2' HD21 ' A' ' 71' ' ' LEU . 12.5 m-20 -127.51 126.13 41.67 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 121.388 -0.82 . . . . 0.0 110.863 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.85 6.07 7.88 Favored Glycine 0 CA--C 1.486 -1.778 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.35 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.91 -9.09 59.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -118.69 172.37 7.55 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.905 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.0 m -84.05 163.9 19.6 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.424 0.63 . . . . 0.0 110.207 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 26' ' ' MET . 72.3 mt -62.81 -28.84 70.28 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.528 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 59.3 tttp -74.4 -37.08 63.49 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.815 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.75 -34.25 77.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 63' ' ' ASP . 96.7 mt -72.46 -13.21 61.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.99 79.53 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.993 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 5' ' ' TYR . 21.9 t -88.65 111.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' TYR . 21.1 mtp180 -123.51 -170.16 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.559 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 p-10 -61.66 145.6 51.75 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 122.031 0.919 . . . . 0.0 112.433 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.27 -6.83 74.5 Favored Glycine 0 C--N 1.288 -2.093 0 CA-C-N 113.905 -1.498 . . . . 0.0 112.997 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.454 ' HB3' HD21 ' A' ' 50' ' ' LEU . 94.4 m-85 -89.13 147.12 24.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 81.3 mtm180 -114.4 136.09 53.38 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.252 0.549 . . . . 0.0 111.212 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 42.4 mm -105.65 129.48 58.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.125 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HA ' ' O ' ' A' ' 10' ' ' THR . 80.6 t60 -116.15 131.31 56.98 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.781 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -110.08 138.37 46.55 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.5 139.75 40.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.37 124.61 28.58 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.36 0.6 . . . . 0.0 111.785 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 12.0 p -116.68 13.22 7.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.412 1.101 . . . . 0.0 108.655 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 4.4 m -76.53 -35.54 58.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.64 -4.31 30.19 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 84' ' ' VAL . . . 64.85 65.53 2.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.797 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -93.38 160.24 14.9 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.363 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 66.09 71.92 0.4 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.592 1.187 . . . . 0.0 108.529 -171.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 C--N 1.296 -1.742 0 CA-C-N 113.969 -1.468 . . . . 0.0 107.753 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.241 0.62 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.4 t -94.91 112.11 23.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.974 0.893 . . . . 0.0 110.32 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.19 133.46 31.41 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.152 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.22 146.18 25.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.575 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -124.23 140.38 53.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -95.44 116.07 28.3 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 79' ' ' ILE . 5.8 mp -108.99 144.61 36.74 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.038 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.1 tt0 -110.22 117.35 33.45 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mm -94.8 132.11 39.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.088 -171.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 165.4 16.57 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.3 m -154.69 169.99 22.6 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -173.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HB3' HG23 ' A' ' 82' ' ' VAL . 23.7 p-10 -84.34 -22.8 30.46 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.63 -32.53 31.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.057 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 p -116.93 128.19 54.97 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.093 0.473 . . . . 0.0 111.337 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -82.98 -26.56 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -84.86 117.36 68.6 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.152 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -74.06 140.76 28.72 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.641 2.227 . . . . 0.0 110.66 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.4 mtt -119.92 127.94 53.15 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -87.17 129.04 35.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.369 0.604 . . . . 0.0 111.183 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.33 135.4 28.64 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -94.09 132.67 38.36 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 120.89 0.376 . . . . 0.0 110.972 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -127.47 154.32 77.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.668 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.45 141.82 35.7 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.21 1.94 . . . . 0.0 111.109 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -68.58 -30.79 69.62 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.245 0.545 . . . . 0.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.03 4.31 83.03 Favored Glycine 0 C--N 1.301 -1.394 0 CA-C-N 114.802 -1.09 . . . . 0.0 114.597 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.1 tpt -87.48 167.19 14.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 118.077 0.938 . . . . 0.0 109.445 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 p -82.92 140.28 32.91 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 120.88 0.372 . . . . 0.0 110.051 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -67.02 -25.94 66.53 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.73 -36.74 77.2 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.566 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.575 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 31.0 t70 -70.14 -37.65 75.32 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.395 0.617 . . . . 0.0 109.526 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.4 tt -66.81 -44.71 80.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 7.7 mtpm? -58.5 -47.71 83.19 Favored 'General case' 0 C--O 1.175 -2.856 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -61.07 -32.43 72.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.007 0.432 . . . . 0.0 110.599 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.4 mptm? -70.39 -42.95 71.04 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 123.619 0.767 . . . . 0.0 110.126 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 80.4 mt -61.38 -47.02 87.74 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.165 0.586 . . . . 0.0 109.835 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.25 -31.37 67.35 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.544 1.537 . . . . 0.0 111.362 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.02 -48.16 54.59 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.3 t -74.57 -41.88 48.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.985 0.422 . . . . 0.0 111.859 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.66 -20.77 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.289 0.566 . . . . 0.0 111.248 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.7 10.48 85.11 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.553 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 m -73.92 163.94 27.27 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.347 0.594 . . . . 0.0 110.575 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.8 p -120.1 155.48 32.92 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.35 -34.96 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 118.324 0.511 . . . . 0.0 110.32 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.39 -43.92 96.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.902 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.8 m -99.92 7.32 44.94 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.6 ttt -96.44 132.79 41.62 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 82' ' ' VAL . 19.8 tpp85 -112.93 119.93 39.65 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.537 HG13 HD13 ' A' ' 61' ' ' LEU . 10.5 tp -98.34 119.28 46.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' NE2' HD11 ' A' ' 57' ' ' LEU . 35.3 tt0 -128.86 139.71 52.03 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 118.409 -1.317 . . . . 0.0 111.013 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.9 tt -107.45 133.1 52.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.459 ' N ' HD23 ' A' ' 50' ' ' LEU . 24.5 m-85 -124.78 121.89 35.9 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.354 0.662 . . . . 0.0 110.36 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -148.87 177.37 9.6 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.51 62.36 1.97 Allowed Glycine 0 C--N 1.286 -2.237 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 69.78 -46.4 0.59 Allowed 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.213 1.405 . . . . 0.0 113.621 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -164.76 -30.54 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -59.97 156.12 15.31 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' NE2' ' A' ' 49' ' ' GLN . 5.8 tt -82.28 125.77 31.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.646 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -43.73 10.33 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.03 -160.31 28.02 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.37 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -100.84 135.77 41.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.969 0.507 . . . . 0.0 110.358 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mp -68.64 -62.97 1.16 Allowed 'General case' 0 C--O 1.205 -1.253 0 CA-C-O 121.094 0.473 . . . . 0.0 110.534 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 61' ' ' LEU 0.316 6.5 t 79.69 -3.77 2.02 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 128.465 2.706 . . . . 0.0 115.2 171.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -138.72 143.7 39.19 Favored 'General case' 0 CA--C 1.489 -1.381 0 O-C-N 122.169 -0.332 . . . . 0.0 110.228 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -136.41 -1.01 2.88 Favored Glycine 0 CA--C 1.487 -1.712 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.332 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.96 -19.19 64.16 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.07 0.938 . . . . 0.0 108.861 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.693 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.5 ptmt -106.01 150.89 25.3 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.379 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.571 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 28.8 p -78.27 172.5 13.49 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' H ' HD12 ' A' ' 68' ' ' LEU . 4.6 mp -60.5 -33.99 73.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.706 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.524 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.2 tmtt? -69.04 -42.74 75.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.182 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.693 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 7.9 t70 -76.76 -29.95 56.33 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.097 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.62 -13.86 60.7 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.31 67.65 Favored Glycine 0 C--N 1.315 -0.625 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.27 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.45 105.29 12.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -84.63 178.87 7.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.663 0.744 . . . . 0.0 112.482 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.05 155.1 30.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.58 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.92 4.45 77.26 Favored Glycine 0 C--N 1.29 -2.026 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.042 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CD2' HD21 ' A' ' 50' ' ' LEU . 5.3 m-30 -81.36 150.11 28.58 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.647 0.379 . . . . 0.0 111.254 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 79.5 mtt180 -105.2 121.73 44.44 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.354 0.597 . . . . 0.0 110.123 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 7' ' ' LEU . 44.5 mm -103.39 119.06 51.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.822 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -99.12 120.25 39.18 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.394 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -104.58 135.35 46.16 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.7 p -150.21 138.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.712 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.08 117.85 30.25 Favored 'General case' 0 N--CA 1.382 -3.864 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.03 -7.42 9.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.721 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.4 m -66.24 -24.9 66.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.762 0.825 . . . . 0.0 110.636 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.03 -5.07 81.18 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.54 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.57 -9.34 8.22 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 113.755 0.262 . . . . 0.0 113.755 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -99.61 147.72 25.07 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 122.29 0.236 . . . . 0.0 110.802 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HB2' HG21 ' A' ' 82' ' ' VAL . 11.7 mm-40 62.61 24.68 14.7 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.179 0.924 . . . . 0.0 111.821 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.033 -179.013 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.2 m -91.92 112.95 25.08 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 24' ' ' ALA . 35.1 tt0 -145.33 92.86 2.3 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.3 m -137.72 162.15 32.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.246 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -122.62 128.4 50.61 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p-10 -80.02 124.26 28.56 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -125.35 151.74 45.67 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.276 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 34.5 tt0 -109.3 121.92 46.22 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.1 mm -96.37 131.49 43.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.826 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -131.25 163.36 27.94 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.635 0.731 . . . . 0.0 109.867 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.9 p -135.69 166.57 22.94 Favored 'General case' 1 N--CA 1.37 -4.44 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -85.55 -17.53 36.04 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.33 -31.3 16.97 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.599 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 16' ' ' PHE . 5.5 m -114.2 153.18 30.06 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -105.63 4.68 30.5 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.579 0.704 . . . . 0.0 109.992 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' H ' HG22 ' A' ' 14' ' ' THR . 77.6 t80 -104.19 116.06 62.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.979 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.77 142.22 7.82 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 122.52 2.147 . . . . 0.0 110.93 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 ttt -134.15 122.7 23.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.117 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.01 144.68 31.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.564 0.697 . . . . 0.0 112.819 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -150.99 130.76 13.18 Favored 'General case' 0 N--CA 1.41 -2.458 0 C-N-CA 125.47 1.508 . . . . 0.0 107.656 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 6' ' ' ASP . 45.6 pttt -96.18 135.57 37.81 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-O 120.898 0.38 . . . . 0.0 109.996 176.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.94 147.74 57.63 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.259 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 37.5 Cg_exo -60.57 143.76 99.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.07 -30.11 64.02 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.402 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 6.35 77.03 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.829 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 1.1 tpt -80.26 146.25 31.76 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' HE2' ' A' ' 26' ' ' MET . 57.2 p -85.51 153.88 22.14 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.359 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.3 -28.93 67.6 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -42.25 99.59 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.122 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.99 -39.51 79.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 tt -65.8 -41.63 91.68 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -58.36 -51.99 67.49 Favored 'General case' 0 C--O 1.183 -2.427 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.303 174.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.3 tppp? -66.21 -30.19 70.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 1.6 tpmt? -63.56 -44.6 93.67 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 54.5 mt -64.09 -45.66 87.66 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.969 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 27.6 mm-40 -64.84 -30.99 72.02 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.766 0.827 . . . . 0.0 111.815 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.87 -34.78 78.93 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.388 0.613 . . . . 0.0 109.607 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.1 t -84.39 -38.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.477 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.87 -27.36 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 111.509 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.59 84.1 Favored Glycine 0 C--N 1.306 -1.093 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.296 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 42' ' ' THR . 23.2 m -98.01 -177.29 3.7 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.611 ' H ' HG22 ' A' ' 41' ' ' THR . 33.4 p -108.17 159.16 16.82 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 32' ' ' LYS . 94.1 t -59.3 -39.1 78.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.75 -32.03 67.28 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.362 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.579 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 50.9 m -85.05 -6.86 59.31 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 9.5 tpt -132.07 112.07 12.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -105.02 142.91 33.97 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 -171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.67 123.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -116.13 143.45 45.48 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.846 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 tt -113.99 126.99 55.75 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.38 136.59 52.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -85.99 -161.4 0.63 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.35 54.18 3.58 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 116.594 -0.275 . . . . 0.0 112.828 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -165.62 -170.72 1.89 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -88.51 -27.27 21.56 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.48 0.657 . . . . 0.0 110.02 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -62.94 154.75 29.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.131 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -82.42 136.05 35.02 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.162 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -83.98 -43.24 15.39 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.52 177.29 38.33 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.935 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -115.92 131.14 57.03 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.681 ' HG ' ' H ' ' A' ' 62' ' ' THR 0.316 0.8 OUTLIER -110.65 -97.13 0.41 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -172.258 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.681 ' H ' ' HG ' ' A' ' 61' ' ' LEU 0.308 3.9 t 80.32 -1.03 1.98 Allowed 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 127.562 2.345 . . . . 0.0 112.001 174.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -83.0 116.27 22.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.92 9.09 25.41 Favored Glycine 0 C--N 1.297 -1.611 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.962 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.14 -8.6 58.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.856 0.836 . . . . 0.0 109.3 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.648 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 17.5 ptmt -126.63 159.06 34.68 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 124.909 1.284 . . . . 0.0 108.667 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 p -85.6 170.56 12.45 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.441 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.49 -32.95 70.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.644 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 38.1 ttpt -74.43 -41.21 61.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.639 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.648 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 13.7 t70 -69.79 -30.18 67.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.73 0.776 . . . . 0.0 109.773 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD13 HD12 ' A' ' 61' ' ' LEU . 34.5 mt -73.63 -11.6 60.47 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.642 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.75 17.55 72.58 Favored Glycine 0 C--N 1.311 -0.839 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.54 119.08 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HD2' ' OH ' ' A' ' 77' ' ' TYR . 95.0 mtt180 -106.84 177.35 4.88 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' OD1' ' A' ' 6' ' ' ASP . 9.0 p-10 -81.37 152.67 27.37 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 3.63 90.64 Favored Glycine 0 C--N 1.289 -2.045 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.996 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HD2' ' A' ' 74' ' ' ARG . 6.2 m-30 -94.96 156.02 16.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 40.5 ptt180 -119.55 136.62 54.27 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.956 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.8 116.75 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.752 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -107.99 126.42 52.7 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.798 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.07 123.94 44.88 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.5 133.16 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-O 121.64 0.734 . . . . 0.0 109.952 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.92 127.36 32.47 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.087 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.93 0.13 9.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.384 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 3.6 m -79.64 -34.46 40.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.286 0.565 . . . . 0.0 109.781 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.25 -0.56 33.31 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.31 70.37 1.09 Allowed Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.532 -0.834 . . . . 0.0 113.325 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.21 143.36 27.37 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.273 -0.545 . . . . 0.0 109.781 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 63.9 92.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 124.37 1.044 . . . . 0.0 111.724 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.207 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.4 p -84.04 113.91 21.36 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.1 0.476 . . . . 0.0 110.182 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 9.9 tp10 -159.93 158.82 31.45 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.64 140.1 41.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 123.66 0.784 . . . . 0.0 109.518 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.71 123.13 45.31 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.49 115.93 20.27 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 79' ' ' ILE . 91.3 mt -114.77 156.74 24.3 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.955 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.72 119.29 38.93 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.14 126.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.685 0.755 . . . . 0.0 110.988 -171.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.54 166.66 21.57 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.111 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -150.56 167.17 28.02 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 82' ' ' VAL . 4.5 p-10 -76.2 -25.98 55.67 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 121.233 0.54 . . . . 0.0 109.592 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.32 -24.18 54.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.772 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 p -109.96 134.01 52.56 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.445 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.96 -20.31 18.83 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -84.25 124.92 73.43 Favored Pre-proline 0 N--CA 1.429 -1.476 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.177 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.4 145.72 24.05 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 123.105 2.537 . . . . 0.0 110.442 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.3 mtm -131.33 122.09 25.8 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.98 123.64 30.76 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.914 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -144.84 130.65 19.14 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.63 133.06 48.27 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.819 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.8 154.21 70.6 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.419 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -68.13 142.29 55.39 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.14 1.893 . . . . 0.0 111.444 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -61.59 -34.3 75.38 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.536 0.684 . . . . 0.0 111.956 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.11 0.93 88.97 Favored Glycine 0 C--N 1.284 -2.31 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.426 -177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.7 tpt -81.19 158.31 24.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.684 -177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 20.2 m -83.46 145.46 28.95 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.733 1.213 . . . . 0.0 110.901 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.6 tt -69.9 -30.72 68.22 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -54.94 -44.48 74.32 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.739 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.06 -34.36 75.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.214 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 5.4 tt -68.6 -39.48 80.86 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 53.2 mtpt -63.25 -38.91 93.02 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.749 175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 9.9 tppt? -66.33 -30.85 71.35 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -68.02 -42.55 80.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 92.9 mt -64.17 -42.25 96.8 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.295 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' OE2' HG22 ' A' ' 43' ' ' VAL . 43.2 mt-10 -60.52 -35.03 74.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 123.418 0.687 . . . . 0.0 110.551 174.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 51.7 tp -75.71 -50.15 16.21 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.202 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.8 t -74.48 -41.49 49.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.7 t -95.5 -26.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.46 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.55 4.04 83.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 119.651 -1.261 . . . . 0.0 112.528 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 42' ' ' THR . 4.3 m -68.15 171.6 6.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 62.1 p -98.21 -172.83 2.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' OE2' ' A' ' 36' ' ' GLU . 20.5 t -88.23 -48.7 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.036 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -77.92 -38.38 45.67 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.055 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 42' ' ' THR . 44.4 m -80.58 -4.5 54.28 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.095 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 40.5 ttp -100.2 112.4 24.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.643 0.735 . . . . 0.0 110.088 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HB3' HG13 ' A' ' 82' ' ' VAL . 77.9 ttt180 -102.21 142.99 32.58 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.882 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 HD12 ' C ' ' A' ' 47' ' ' ARG . 2.4 mp -126.6 125.63 67.47 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.658 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.441 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 HE22 HG11 ' A' ' 82' ' ' VAL . 1.4 mp0 -109.73 138.2 46.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 57' ' ' LEU . 5.4 tt -111.28 113.67 26.31 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.537 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' CE1' HD13 ' A' ' 57' ' ' LEU . 84.8 m-85 -110.63 146.9 35.35 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' OD2' ' HE2' ' A' ' 58' ' ' LYS . 3.0 p30 -89.22 -176.27 5.05 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.212 174.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.88 17.69 48.46 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -99.28 -50.29 4.18 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.6 t70 174.88 -39.74 0.01 OUTLIER 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.119 0.887 . . . . 0.0 113.124 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -102.21 155.8 17.98 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 -164.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 50' ' ' LEU . 63.4 tp -83.32 130.43 35.06 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.427 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HE2' ' OD2' ' A' ' 52' ' ' ASP . 74.2 mmtt -89.03 -38.96 14.01 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.387 0.613 . . . . 0.0 110.847 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.62 35.82 Favored Glycine 0 C--N 1.285 -2.261 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.76 128.39 50.43 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD1' ' H ' ' A' ' 62' ' ' THR 0.392 1.0 OUTLIER 38.43 -94.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 176.534 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.585 ' H ' ' CD1' ' A' ' 61' ' ' LEU . 32.0 m 82.16 -3.58 1.47 Allowed 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 126.612 1.965 . . . . 0.0 112.742 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 t70 176.0 -162.79 0.03 OUTLIER 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 174.23 -3.28 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.581 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' H ' ' H ' ' A' ' 64' ' ' GLY . . . -89.27 -20.24 24.36 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -90.02 160.14 16.5 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 174.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 47.9 p -82.7 169.38 16.26 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.241 0.543 . . . . 0.0 112.16 -171.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.16 -30.59 71.52 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.58 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 9.2 tmtt? -70.36 -44.05 68.9 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 66' ' ' LYS . 50.1 t0 -71.16 -31.61 67.89 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.168 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.03 -12.18 60.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 21.15 58.37 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.974 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.96 131.38 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 22.7 mmm180 -124.76 176.83 6.33 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.96 144.23 43.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.545 0.688 . . . . 0.0 111.107 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 7.73 86.64 Favored Glycine 0 C--N 1.29 -2.0 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.853 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.9 m-85 -90.94 149.59 21.82 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -105.57 121.88 44.87 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 7' ' ' LEU . 46.9 mt -105.2 114.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -110.14 119.86 40.63 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.823 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -97.79 144.3 27.52 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.522 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 12.1 p -140.57 138.33 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 120.878 0.37 . . . . 0.0 110.719 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.18 121.19 27.12 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.518 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.77 -27.0 12.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.966 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -65.38 -31.83 73.15 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 111.539 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.44 7.65 80.06 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.696 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.27 38.49 93.34 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -83.14 130.6 35.12 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.424 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.459 ' HG2' HG21 ' A' ' 82' ' ' VAL 0.349 11.6 pt-20 60.45 -34.74 0.08 Allowed 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 127.335 2.254 . . . . 0.0 116.949 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.261 -3.242 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -99.56 136.85 38.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.333 0.396 . . . . 0.0 111.162 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 6.9 mp0 -115.9 136.25 53.22 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.38 142.36 39.9 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.653 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 3.6 p90 -124.11 141.4 52.08 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.999 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -101.28 114.81 29.12 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -126.54 158.76 35.34 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 34.9 tt0 -108.01 123.63 48.95 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.4 135.82 34.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.926 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 12.5 p -118.8 144.06 46.55 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.425 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 3.8 m -139.92 164.84 28.92 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' HB3' HG23 ' A' ' 82' ' ' VAL . 20.5 p-10 -74.76 -16.76 60.71 Favored 'General case' 0 C--N 1.253 -3.622 0 C-N-CA 124.525 1.13 . . . . 0.0 111.028 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.18 14.36 20.61 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 11' ' ' THR . 43.1 p -114.14 128.79 56.54 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.54 -20.57 21.56 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 75.6 t80 -129.58 125.47 22.37 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.008 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 33.0 Cg_exo -61.4 150.22 86.0 Favored 'Trans proline' 0 N--CA 1.48 0.723 0 C-N-CA 123.834 3.023 . . . . 0.0 113.538 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.1 ttt -119.62 124.0 45.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.772 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.22 137.37 32.39 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -153.32 142.3 21.24 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 52.4 tttp -104.15 125.65 50.63 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 93.3 m-85 -131.32 163.37 49.91 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 11.2 Cg_exo -72.98 143.68 36.84 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.159 1.906 . . . . 0.0 111.141 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 67' ' ' SER . . . -79.49 -9.54 59.63 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.922 0.392 . . . . 0.0 111.776 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.26 -4.09 71.69 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -72.02 157.46 37.76 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 12.8 m -92.02 136.81 32.87 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 122.287 -0.258 . . . . 0.0 110.408 -174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 tm? -56.36 -40.44 74.54 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -64.08 -37.96 89.32 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.54 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.03 -33.72 65.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.8 tt -62.66 -46.19 89.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.481 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 44.2 mtpt -59.41 -48.16 82.68 Favored 'General case' 0 C--O 1.179 -2.653 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 34.6 ttmt -60.41 -32.36 71.26 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 123.544 0.737 . . . . 0.0 111.95 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -69.31 -43.62 73.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 mt -64.98 -37.84 89.0 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.47 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 5.5 mm-40 -61.07 -30.25 70.23 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 124.473 1.109 . . . . 0.0 112.802 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.06 -29.99 71.25 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.506 0.67 . . . . 0.0 109.312 174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.82 -41.1 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.663 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.33 -28.1 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.67 -8.43 59.32 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.323 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -84.41 -171.49 3.65 Favored 'General case' 0 C--O 1.253 1.283 0 CA-C-N 117.571 0.686 . . . . 0.0 111.796 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.21 156.75 20.23 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.86 -30.03 41.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.9 0.381 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 m -88.44 -4.28 58.67 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.468 0.651 . . . . 0.0 110.991 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HG3' ' OE1' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -99.93 121.49 41.42 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.625 -178.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.738 ' HD3' ' OE2' ' A' ' 60' ' ' GLU . 7.5 tpp180 -111.92 136.43 51.25 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 32' ' ' LYS . 21.3 mt -118.19 131.63 70.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.425 0.631 . . . . 0.0 110.919 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -116.4 138.79 51.07 Favored 'General case' 0 N--CA 1.396 -3.136 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.82 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 61' ' ' LEU . 5.4 tt -105.85 128.22 53.61 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.77 135.17 53.82 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 56' ' ' GLN . 31.1 t70 -150.91 171.36 17.37 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' GLN . . . 70.27 38.86 71.64 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -172.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 72.11 -67.26 0.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.657 1.583 . . . . 0.0 112.213 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -131.62 -2.39 3.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.739 0.781 . . . . 0.0 110.94 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 67.0 mt-30 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.971 0.891 . . . . 0.0 111.998 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.12 122.33 28.68 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.25 -43.01 11.28 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.46 26.94 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.82 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.738 ' OE2' ' HD3' ' A' ' 47' ' ' ARG . 5.8 tp10 -100.06 126.92 46.34 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 123.937 0.895 . . . . 0.0 109.298 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 50' ' ' LEU . 93.3 mt -72.74 -95.02 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.771 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.368 1.1 m 79.12 -3.12 2.19 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.76 -72.67 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' SER . . . 70.52 -7.98 4.53 Favored Glycine 0 C--O 1.211 -1.307 0 N-CA-C 117.408 1.723 . . . . 0.0 117.408 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.06 -4.07 59.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.889 1.345 . . . . 0.0 110.174 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -124.43 -177.42 3.79 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.874 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 27.1 p -82.23 163.29 21.97 Favored 'General case' 0 N--CA 1.391 -3.407 0 CA-C-O 122.092 0.949 . . . . 0.0 111.114 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 26' ' ' MET . 75.1 mt -71.07 -25.94 62.85 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-N 113.782 -1.554 . . . . 0.0 109.0 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 39.1 ttpt -65.68 -45.36 83.16 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.439 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -69.93 -30.68 68.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.714 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.33 -14.13 60.84 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.691 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.7 17.04 31.9 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.066 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.04 109.44 20.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 28.7 mmt180 -124.27 -176.09 3.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 5' ' ' TYR . 5.5 m-20 -67.41 144.04 55.98 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 -14.17 57.93 Favored Glycine 0 C--N 1.276 -2.762 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.106 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 27.5 m-85 -78.63 156.38 29.11 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 117.42 0.61 . . . . 0.0 109.838 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 63.8 mtm180 -122.48 132.94 54.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.171 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 48' ' ' ILE . 50.4 mt -110.65 135.55 49.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.58 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 10' ' ' THR . 77.3 t60 -112.51 136.8 51.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.299 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 11' ' ' THR . . . -119.98 134.08 55.35 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.697 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 47' ' ' ARG . 8.3 p -152.47 135.56 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.34 138.93 32.36 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.93 -9.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.318 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.7 m -66.47 -32.1 73.26 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.956 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.04 1.6 74.28 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.649 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.58 31.64 80.54 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.23 148.42 39.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 71.33 69.44 0.17 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.324 1.449 . . . . 0.0 112.05 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 113.096 -1.866 . . . . 0.0 106.309 178.558 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 CA--C 1.494 -1.173 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 p -75.46 112.93 12.29 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.633 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 40.9 tt0 -100.54 67.12 1.28 Allowed 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 122.556 1.169 . . . . 0.0 109.626 -168.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 m -140.06 148.98 22.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.714 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -123.95 141.24 52.22 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -95.99 115.96 28.22 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.38 156.13 17.64 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.47 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 42.9 tt0 -110.17 114.67 28.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.56 128.84 50.92 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 121.37 0.605 . . . . 0.0 110.363 -176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 p -120.25 150.61 40.41 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.07 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 14' ' ' THR . 3.2 m -142.9 159.31 42.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.317 1.056 . . . . 0.0 109.896 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 25.1 t30 -50.6 -35.29 29.55 Favored 'General case' 0 C--N 1.259 -3.365 0 C-N-CA 128.59 2.756 . . . . 0.0 113.103 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 89' ' ' GLU . . . -127.19 16.12 7.23 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.403 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 11' ' ' THR . 72.9 p -117.94 129.01 55.35 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.3 -25.07 20.7 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.452 0.644 . . . . 0.0 109.656 177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -93.36 123.21 61.17 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.872 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.96 147.04 18.71 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.66 2.24 . . . . 0.0 111.182 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.9 ttm -110.83 137.32 48.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.81 127.93 49.78 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.82 0.343 . . . . 0.0 110.285 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -142.13 150.15 40.73 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.431 0.692 . . . . 0.0 110.436 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.52 130.02 49.23 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 85.0 m-85 -136.16 136.55 22.92 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 35.2 Cg_exo -60.62 140.69 92.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.517 2.145 . . . . 0.0 111.219 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -65.26 -22.92 66.92 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.282 0.563 . . . . 0.0 112.044 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.34 1.85 80.12 Favored Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.353 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.445 ' HE3' ' HA ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -81.9 154.58 25.74 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.44 ' H ' ' HE2' ' A' ' 26' ' ' MET . 28.4 p -83.73 149.84 26.21 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.206 0.527 . . . . 0.0 110.107 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 32.3 tp -64.68 -33.43 75.94 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.781 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -65.95 -31.18 71.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.915 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.15 -35.22 59.29 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.92 -45.03 83.42 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.101 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 50.6 mtpt -58.78 -49.95 75.76 Favored 'General case' 0 C--O 1.174 -2.895 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.38 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.85 -35.74 75.4 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 123.348 0.659 . . . . 0.0 111.365 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -65.84 -42.06 90.99 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -67.06 -39.73 86.96 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.804 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 6.5 mm-40 -62.09 -30.21 70.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.323 1.049 . . . . 0.0 112.466 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.56 -29.02 70.34 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.45 -41.27 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.457 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.54 -28.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.15 -7.81 80.31 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.035 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 42' ' ' THR . 18.4 m -90.6 -179.91 5.67 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 41' ' ' THR . 44.8 p -101.79 154.9 18.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 O-C-N 121.993 -0.442 . . . . 0.0 110.777 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.65 -32.01 45.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.794 0.838 . . . . 0.0 112.189 -173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -68.32 -37.64 80.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.709 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.6 m -86.16 -3.12 58.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.36 0.6 . . . . 0.0 111.405 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.609 ' SD ' ' HE3' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.74 128.32 43.57 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 82' ' ' VAL . 80.1 ttt180 -125.54 142.16 51.66 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.516 HD11 ' HG2' ' A' ' 32' ' ' LYS . 49.1 mt -121.29 134.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -119.74 139.47 52.23 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.436 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD22 ' HG3' ' A' ' 58' ' ' LYS . 5.5 tt -113.32 126.53 55.48 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.538 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB2' ' HG3' ' A' ' 78' ' ' ARG . 68.5 m-85 -118.31 138.36 52.44 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 55' ' ' ASP . 6.0 p-10 -92.25 -168.42 1.98 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.018 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.5 -51.35 58.3 Favored Glycine 0 CA--C 1.523 0.553 0 O-C-N 124.152 0.908 . . . . 0.0 112.798 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -165.69 86.63 0.37 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.453 0.644 . . . . 0.0 111.947 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 17.2 t70 -167.96 17.94 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 172.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.412 ' H ' ' H ' ' A' ' 55' ' ' ASP . 72.3 mm-40 60.19 -165.08 0.21 Allowed 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 112.285 -2.234 . . . . 0.0 112.828 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' LEU . 61.0 tp -57.55 132.54 53.5 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.237 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 5.3 mmpt? -83.05 -44.02 15.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.73 38.1 Favored Glycine 0 N--CA 1.415 -2.765 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.175 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.95 116.14 28.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 61' ' ' LEU 0.364 0.9 OUTLIER -94.43 -101.18 0.15 Allowed 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -178.011 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 61' ' ' LEU 0.341 6.6 t 79.56 5.17 2.08 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 127.403 2.281 . . . . 0.0 113.274 175.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB2' HD21 ' A' ' 71' ' ' LEU . 5.6 m-20 -54.42 -76.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.493 0.663 . . . . 0.0 111.687 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 28' ' ' LEU . . . 70.85 -1.37 23.66 Favored Glycine 0 C--O 1.219 -0.82 0 CA-C-N 115.497 -0.774 . . . . 0.0 114.555 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.66 3.71 18.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.964 0.887 . . . . 0.0 109.622 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -144.69 179.56 7.22 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.744 1.218 . . . . 0.0 108.331 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 39.3 p -82.75 169.48 16.13 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-O 121.522 0.677 . . . . 0.0 112.03 -176.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.92 -31.01 71.69 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.525 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -69.25 -41.11 77.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.553 -177.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.97 -29.86 61.03 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.806 0.812 . . . . 0.0 109.343 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 63' ' ' ASP . 85.9 mt -75.23 -13.83 60.48 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.058 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.61 19.1 60.61 Favored Glycine 0 C--N 1.31 -0.902 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.117 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.44 121.06 36.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.599 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 34.9 mmt180 -122.92 -179.71 4.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.915 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.15 142.19 43.58 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.296 0.569 . . . . 0.0 110.003 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.86 -2.23 80.88 Favored Glycine 0 C--N 1.271 -3.056 0 CA-C-N 114.786 -1.097 . . . . 0.0 114.605 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 21.7 m-85 -87.18 152.12 22.6 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 117.483 0.641 . . . . 0.0 109.985 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' GLU . 7.3 ptp180 -105.23 132.59 51.24 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.324 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.14 120.78 51.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.398 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -98.26 117.36 32.47 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.24 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.03 136.5 38.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.246 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 9.2 p -143.54 132.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.59 128.72 39.88 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.4 m -83.07 -8.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 120.849 0.357 . . . . 0.0 111.723 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -84.51 -31.75 24.3 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.9 -1.69 56.15 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.04 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.8 -136.13 35.7 Favored Glycine 0 C--O 1.212 -1.273 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 88' ' ' ASN . 10.4 m120 -99.01 121.72 41.33 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 118.364 1.082 . . . . 0.0 111.9 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 13' ' ' ALA . 43.8 mt-10 52.49 85.2 0.05 OUTLIER 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.023 1.329 . . . . 0.0 113.771 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.266 177.641 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.2 mtp . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -94.22 112.81 24.64 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 9.3 tp10 -135.96 143.94 45.14 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.6 m -133.03 137.39 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.283 0.563 . . . . 0.0 111.706 -174.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 68' ' ' LEU . 8.7 p90 -124.65 142.36 51.43 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.926 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -94.82 131.74 40.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 170.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 63.4 mt -125.06 157.12 37.03 Favored 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 123.565 0.746 . . . . 0.0 111.967 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.4 114.65 28.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 168.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.8 mp -100.61 134.48 40.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.833 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 p -132.9 163.88 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.295 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 5.2 m -153.51 167.15 30.46 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 104.189 -2.522 . . . . 0.0 104.189 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -90.33 -15.49 31.04 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-O 121.638 0.732 . . . . 0.0 109.611 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.89 -16.2 45.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.982 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.4 p -113.47 157.67 21.68 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.904 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.23 -18.03 10.05 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.441 0.639 . . . . 0.0 110.329 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -101.25 113.34 65.82 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.784 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.46 128.4 17.19 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.664 2.243 . . . . 0.0 110.258 174.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -112.93 141.5 46.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.29 132.04 54.53 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.356 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -153.2 150.17 28.74 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.977 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 40.1 ttmt -97.12 134.99 39.73 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.837 0.71 . . . . 0.0 109.87 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 96.2 m-85 -135.63 162.45 57.03 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 4.9 Cg_exo -77.13 136.97 16.74 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.303 2.002 . . . . 0.0 112.648 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.55 59.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.315 0.579 . . . . 0.0 112.294 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.78 -6.21 88.68 Favored Glycine 0 C--N 1.3 -1.428 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.671 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.4 ttp -79.49 160.41 26.56 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.77 0.319 . . . . 0.0 110.222 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.0 p -84.54 150.53 25.17 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -64.61 -32.84 74.68 Favored 'General case' 0 C--O 1.186 -2.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.98 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.24 -30.69 70.6 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 15.1 t70 -68.98 -45.07 71.57 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.83 -40.88 92.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.505 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HE2' HG13 ' A' ' 43' ' ' VAL . 25.0 mmmt -55.15 -49.08 72.72 Favored 'General case' 0 C--O 1.179 -2.624 0 C-N-CA 123.933 0.893 . . . . 0.0 110.396 173.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -60.07 -34.76 73.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 109.635 -177.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -68.94 -43.21 75.55 Favored 'General case' 0 N--CA 1.421 -1.9 0 C-N-CA 123.698 0.799 . . . . 0.0 110.158 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.57 -47.35 84.21 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 123.604 0.762 . . . . 0.0 110.012 175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -56.82 -35.58 68.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 125.461 1.505 . . . . 0.0 111.104 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.22 -37.59 66.36 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.013 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.2 t -80.11 -41.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -90.56 -27.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.41 1.72 71.41 Favored Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.078 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 42' ' ' THR . 9.8 m -83.0 173.14 12.04 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.105 0.478 . . . . 0.0 111.109 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.532 ' H ' HG22 ' A' ' 41' ' ' THR . 34.4 p -100.65 -167.04 1.38 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.463 1.105 . . . . 0.0 109.424 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 32' ' ' LYS . 83.9 t -80.25 -48.67 19.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.84 -32.5 31.15 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' HG22 ' A' ' 84' ' ' VAL . 51.1 m -76.64 -8.92 58.19 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.111 0.481 . . . . 0.0 111.97 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 21.3 ttt -109.63 111.21 22.57 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 5.3 tpt180 -95.84 140.01 31.23 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.652 -175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 HD21 ' A' ' 61' ' ' LEU . 35.5 mm -117.51 126.95 74.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.76 138.32 49.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.442 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB2' HD22 ' A' ' 61' ' ' LEU . 6.3 tt -113.56 120.28 40.42 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 121.622 0.725 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HB2' ' CG ' ' A' ' 78' ' ' ARG . 80.1 m-85 -107.16 144.44 33.89 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 13.4 t70 -81.69 -151.84 0.09 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . -73.04 -16.9 78.42 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -97.18 165.12 12.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 123.175 0.59 . . . . 0.0 112.321 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.74 152.34 43.91 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.9 tp -82.46 131.21 35.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.34 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -88.1 -41.72 12.86 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.821 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.77 -166.48 38.71 Favored Glycine 0 N--CA 1.425 -2.04 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -116.21 136.8 52.69 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 61' ' ' LEU . 1.2 pt? -118.49 -155.08 0.59 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 61' ' ' LEU . 5.4 t 108.0 10.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 127.414 2.286 . . . . 0.0 110.024 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.91 -74.55 0.09 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.179 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.93 -7.85 13.84 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 114.698 0.639 . . . . 0.0 114.698 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.51 7.9 24.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 109.241 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.525 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.7 ptmt -143.8 158.54 43.61 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -78.69 168.6 19.52 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.722 0.772 . . . . 0.0 111.235 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 5' ' ' TYR . 54.3 mt -69.46 -27.75 65.5 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.663 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.24 -40.15 67.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 15.0 t70 -73.03 -29.39 62.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.76 -14.23 61.08 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.007 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.61 15.18 55.59 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.552 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -80.65 92.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 98.0 mtt180 -110.16 -170.88 1.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.332 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -71.13 144.22 50.32 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.473 0.654 . . . . 0.0 110.77 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.11 82.97 Favored Glycine 0 C--N 1.283 -2.392 0 CA-C-N 114.555 -1.202 . . . . 0.0 114.003 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 52' ' ' ASP . 15.7 m-85 -89.09 156.34 18.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.362 0.601 . . . . 0.0 111.187 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 51' ' ' PHE . 6.1 ptp180 -118.6 135.19 54.57 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 mm -114.14 119.42 61.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.292 0.568 . . . . 0.0 109.507 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -108.94 131.63 54.85 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.608 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -116.01 146.12 42.41 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.05 133.58 53.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.072 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.02 119.66 35.9 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 45' ' ' SER . 34.8 m -103.43 4.21 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.293 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 m -71.9 -33.47 68.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 109.833 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.17 9.37 54.24 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.32 39.69 98.07 Favored Glycine 0 CA--C 1.5 -0.858 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.53 123.44 34.94 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.086 0.469 . . . . 0.0 111.309 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.41 12.0 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.764 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.388 178.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.506 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -97.93 116.66 30.59 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.824 0.821 . . . . 0.0 111.863 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -136.18 132.35 35.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.71 140.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.214 0.531 . . . . 0.0 111.186 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.51 ' OH ' HD13 ' A' ' 68' ' ' LEU . 16.3 p90 -125.53 140.22 52.94 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.286 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.79 134.06 34.05 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.66 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.4 mt -118.89 156.83 28.8 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 123.899 0.88 . . . . 0.0 111.08 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -108.55 114.24 27.91 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' PRO . 46.3 mm -99.01 127.84 51.25 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.582 -172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.15 159.24 29.0 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.191 175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 4.2 m -154.1 168.75 25.44 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 11' ' ' THR . 23.3 p-10 -86.08 -20.69 28.37 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 121.695 0.759 . . . . 0.0 109.492 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.7 -36.71 43.12 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.455 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.6 p -116.21 127.2 54.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.83 -27.88 36.36 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.665 0.745 . . . . 0.0 110.438 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 82.8 m-85 -91.66 115.93 65.47 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.741 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 10.4 Cg_exo -70.76 145.9 52.59 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.915 2.41 . . . . 0.0 111.805 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 mmt -126.83 141.08 51.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 2.9 mp0 -83.14 128.35 34.41 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.198 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -134.55 152.72 51.97 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.384 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -100.07 130.28 46.2 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.797 -177.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 77.8 m-85 -133.86 147.57 64.76 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.041 0.136 . . . . 0.0 111.296 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 22' ' ' TYR . 4.3 Cg_exo -75.82 131.81 13.73 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.483 2.122 . . . . 0.0 111.082 177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -68.08 -28.75 67.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.721 0.772 . . . . 0.0 112.198 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.07 -3.22 89.17 Favored Glycine 0 C--N 1.293 -1.847 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.957 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.5 ttp -81.67 167.48 19.14 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.0 p -93.0 152.16 19.47 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.481 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.465 ' H ' ' HA2' ' A' ' 64' ' ' GLY . 2.6 tm? -66.23 -28.52 68.8 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -55.23 -47.6 75.14 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.743 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 16.6 t70 -68.54 -41.37 79.97 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.069 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -61.76 -43.9 97.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -56.98 -52.49 65.02 Favored 'General case' 0 C--O 1.186 -2.242 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.015 174.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 35.6 ttmt -61.94 -31.51 71.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.8 mptm? -72.88 -33.89 66.35 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 123.007 0.523 . . . . 0.0 110.949 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.3 mt -71.82 -35.85 70.04 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.123 0.569 . . . . 0.0 110.188 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 46.3 mm-40 -62.87 -31.24 72.24 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.871 0.869 . . . . 0.0 110.882 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.03 -28.99 67.06 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.728 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.83 -41.4 15.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.654 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.7 t -85.19 -27.83 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.057 0.456 . . . . 0.0 111.752 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.49 18.04 79.9 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.928 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 36' ' ' GLU . 11.1 t -102.4 -162.3 0.91 Allowed 'General case' 0 C--O 1.244 0.78 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.032 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -120.69 154.29 35.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG13 ' HD3' ' A' ' 32' ' ' LYS . 60.3 t -59.11 -42.94 88.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -167.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.25 -43.93 95.7 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -82.37 -0.61 46.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.543 ' CE ' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -124.56 114.99 20.13 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.284 -173.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' NH2' HG21 ' A' ' 84' ' ' VAL 0.251 0.1 OUTLIER -105.73 143.88 33.25 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -175.881 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.72 125.0 61.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.59 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.61 144.46 42.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 122.635 0.374 . . . . 0.0 111.67 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB2' HD22 ' A' ' 61' ' ' LEU . 5.5 tt -111.87 121.25 44.55 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.949 0.404 . . . . 0.0 110.323 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 17.2 m-85 -119.59 122.11 40.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 8.1 t70 173.23 -164.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.483 ' H ' ' CG ' ' A' ' 52' ' ' ASP . . . 74.64 -63.69 2.27 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.97 -66.69 0.9 Allowed 'General case' 0 C--N 1.273 -2.717 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 174.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 163.55 -37.53 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -81.56 -178.6 7.02 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 50' ' ' LEU . 56.2 tp -63.19 136.44 57.74 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.661 0.784 . . . . 0.0 111.501 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -98.36 -44.01 6.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.61 0.719 . . . . 0.0 109.138 172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.37 48.24 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.44 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -101.99 122.75 44.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 61' ' ' LEU 0.313 1.1 pt? -94.51 -110.79 0.12 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 61' ' ' LEU 0.298 2.2 t 79.61 6.39 1.93 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 126.998 2.119 . . . . 0.0 111.778 173.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.85 -73.56 0.05 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.934 0.894 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 28' ' ' LEU . . . 76.74 -24.36 1.9 Allowed Glycine 0 C--O 1.209 -1.423 0 N-CA-C 116.086 1.194 . . . . 0.0 116.086 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.55 10.59 2.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.199 1.0 . . . . 0.0 110.686 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -146.74 162.23 38.98 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 178.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 13.6 m -75.51 162.49 28.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 118.758 0.708 . . . . 0.0 110.883 -168.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD13 ' OH ' ' A' ' 5' ' ' TYR . 86.0 mt -65.93 -30.58 71.18 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.35 176.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 tmtp? -76.8 -41.69 43.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.69 -32.48 74.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.177 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 67' ' ' SER . 80.7 mt -73.99 -13.13 60.82 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.066 176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.22 59.13 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.062 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 t -91.13 103.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.55 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 23.2 mmm180 -102.27 -179.56 4.02 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.694 0.759 . . . . 0.0 113.032 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -71.41 146.22 48.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.174 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.25 -8.19 77.79 Favored Glycine 0 C--N 1.286 -2.213 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.127 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 1.7 m-85 -80.77 157.03 25.92 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 51' ' ' PHE . 2.5 ptp180 -115.41 130.41 56.88 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.15 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.9 mm -104.65 121.57 56.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.823 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -100.96 117.84 35.81 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.096 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -99.29 137.17 38.18 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.699 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.98 132.29 13.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.224 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 31.5 t70 -102.24 140.09 36.98 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG21 ' NH2' ' A' ' 47' ' ' ARG . 41.4 t -101.95 -27.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -172.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 -35.05 13.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 118.596 -1.241 . . . . 0.0 113.521 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.46 -3.44 29.05 Favored Glycine 0 CA--C 1.474 -2.51 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 83' ' ' ASP . . . -93.68 141.3 15.47 Favored Glycine 0 N--CA 1.415 -2.756 0 CA-C-N 114.144 -1.028 . . . . 0.0 111.419 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -100.88 144.97 29.19 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 120.915 0.388 . . . . 0.0 111.72 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.44 18.76 3.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 166.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 C--O 1.258 1.512 0 CA-C-N 111.925 -2.398 . . . . 0.0 107.99 -179.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -78.55 113.7 16.81 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -117.65 133.76 55.61 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.48 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 34.8 m -126.06 158.12 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.586 -176.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 1.9 p90 -112.48 142.19 45.33 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.322 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' OD1' ' HE2' ' A' ' 21' ' ' LYS . 6.7 m-20 -105.53 115.07 29.62 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 172.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 93.6 mt -119.24 152.66 36.26 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.214 0.53 . . . . 0.0 111.584 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -111.29 122.37 47.69 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.447 HD13 ' HB ' ' A' ' 79' ' ' ILE . 35.7 mm -100.3 135.14 37.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -173.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 p -124.28 159.27 30.61 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.2 m -150.94 165.13 34.62 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -80.49 -25.77 38.58 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-O 121.628 0.728 . . . . 0.0 109.587 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.74 -26.12 24.36 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.658 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 58.8 p -100.7 136.94 39.77 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.569 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -93.44 -36.32 12.53 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -87.34 116.64 66.77 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.77 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.67 148.3 77.59 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.78 2.32 . . . . 0.0 111.546 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 mmt -114.59 156.24 25.04 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.53 129.76 56.69 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.071 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -127.79 131.13 49.64 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.51 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 39.9 ttmt -115.74 115.55 26.52 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 87.1 m-85 -146.78 157.91 46.6 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 7.7 Cg_endo -54.36 134.73 62.63 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 123.535 2.823 . . . . 0.0 114.069 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -74.88 -17.39 60.59 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 111.271 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.57 -8.62 85.87 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.974 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.3 tpp -73.43 157.61 36.55 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 p -84.09 154.78 22.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.649 0.738 . . . . 0.0 112.616 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HA ' HD21 ' A' ' 68' ' ' LEU . 3.2 tm? -61.94 -33.69 74.72 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.316 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.92 -30.53 71.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.324 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 20.8 t70 -75.52 -35.11 60.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.96 -43.54 74.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -62.33 -40.56 96.76 Favored 'General case' 0 C--O 1.157 -3.792 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.799 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -63.67 -35.8 81.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.309 0.576 . . . . 0.0 110.396 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 14.2 mptt -72.78 -42.99 63.38 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.059 0.543 . . . . 0.0 110.557 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.73 -28.0 63.38 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.042 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.99 -38.51 73.14 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.189 1.395 . . . . 0.0 107.764 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -75.04 -32.35 61.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 34' ' ' LYS . 60.7 t -84.16 -42.02 16.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.03 0.443 . . . . 0.0 111.676 -176.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -91.34 -27.16 4.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.088 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.56 -8.69 79.3 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 p -75.16 149.98 38.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 122.671 0.388 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.2 p -82.49 179.04 7.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.07 -48.64 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.26 -27.08 32.63 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.186 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.5 m -79.31 1.57 24.53 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.229 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 14.9 ttt -116.9 115.01 24.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.142 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -102.5 141.48 35.26 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.265 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 9.5 tp -115.38 119.16 61.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.769 -172.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' A' ' 60' ' ' GLU . 1.9 mp0 -112.05 140.66 46.54 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 73' ' ' VAL . 51.1 tp -108.76 132.69 53.73 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 80' ' ' HIS . 45.5 m-85 -102.51 130.69 49.41 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' ASP . 12.7 t70 -90.04 147.8 23.44 Favored 'General case' 0 CA--C 1.46 -2.493 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 44.79 -66.79 0.0 OUTLIER Glycine 0 C--N 1.272 -3.011 0 C-N-CA 127.182 2.325 . . . . 0.0 115.46 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.6 t70 -163.84 122.64 1.95 Allowed 'General case' 0 C--N 1.282 -2.334 0 C-N-CA 126.325 1.85 . . . . 0.0 109.528 -175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.8 -51.75 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -55.8 118.9 5.0 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.2 122.56 28.55 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.285 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.19 -43.42 12.24 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.512 0.672 . . . . 0.0 110.222 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.61 -150.57 22.5 Favored Glycine 0 CA--C 1.481 -2.081 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.559 ' HG3' HE21 ' A' ' 49' ' ' GLN . 2.4 mp0 -99.09 146.9 25.61 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 71' ' ' LEU . 89.6 mt -78.9 -84.62 0.08 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.239 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m 79.94 -3.44 1.99 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.962 167.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' HD11 ' A' ' 71' ' ' LEU . 14.0 m-20 -113.25 113.3 25.1 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.052 -1.03 . . . . 0.0 111.312 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.28 4.79 41.03 Favored Glycine 0 C--N 1.285 -2.273 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.083 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.83 -6.71 50.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.583 0.706 . . . . 0.0 110.206 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -131.44 -179.65 5.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 p -89.88 166.01 13.76 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 121.713 0.768 . . . . 0.0 110.607 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 28' ' ' LEU . 56.2 mt -66.39 -29.17 69.27 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.745 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.0 tttt -65.19 -39.99 93.62 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.893 178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.98 -29.86 64.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.564 0.697 . . . . 0.0 109.536 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 61' ' ' LEU . 77.8 mt -73.99 -11.36 60.32 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.606 177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.55 62.76 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.87 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 43.4 t -82.7 92.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.66 -177.55 4.14 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.75 142.23 56.33 Favored 'General case' 0 CA--C 1.496 -1.118 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.189 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.13 64.8 Favored Glycine 0 C--N 1.286 -2.196 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.849 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -83.85 157.06 22.15 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.466 0.65 . . . . 0.0 112.211 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 94.9 mtt180 -121.41 133.43 55.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.457 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 9' ' ' ILE . 18.3 mm -102.68 136.44 35.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 82.5 t60 -116.51 120.63 39.34 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.937 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -103.67 147.65 26.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.69 139.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -84.64 140.68 31.17 Favored 'General case' 0 N--CA 1.401 -2.914 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.84 6.93 8.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.3 t -81.39 -32.07 32.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.281 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.84 -2.98 60.94 Favored Glycine 0 C--N 1.314 -0.693 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.489 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.66 21.7 79.46 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -78.71 139.1 38.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.48 -0.36 . . . . 0.0 110.067 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 66.06 15.63 10.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.672 1.189 . . . . 0.0 111.79 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.284 -176.777 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.237 0.399 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -99.55 120.2 39.26 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.32 71.54 1.47 Allowed 'General case' 0 CA--C 1.484 -1.559 0 CA-C-O 121.933 0.873 . . . . 0.0 109.457 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.42 144.37 37.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.199 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 22' ' ' TYR . 7.8 p90 -124.96 139.82 53.48 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.883 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -103.46 115.91 31.42 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 167.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 83.2 mt -110.46 155.81 21.71 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.034 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.5 113.94 27.16 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.12 138.79 21.81 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.147 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -136.17 160.94 37.14 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m -154.31 166.94 31.61 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -173.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -81.92 -24.68 35.49 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.465 0.65 . . . . 0.0 109.472 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 0.94 56.73 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.429 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.0 p -117.62 141.65 48.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -88.54 -47.11 8.56 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -105.04 138.95 19.66 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.864 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.14 149.2 90.32 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.792 2.328 . . . . 0.0 111.918 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.9 mtp -124.29 125.59 44.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 47.4 mt-10 -101.1 130.3 47.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -153.05 142.65 21.86 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 5' ' ' TYR . 38.7 ttpt -105.37 135.9 45.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 5' ' ' TYR . 90.8 m-85 -140.54 166.41 23.32 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.82 143.7 30.04 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.505 2.137 . . . . 0.0 112.523 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.77 -10.46 59.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.143 0.497 . . . . 0.0 112.012 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.25 -14.78 78.24 Favored Glycine 0 C--N 1.311 -0.814 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.7 ttt -68.67 156.09 38.83 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.814 1.246 . . . . 0.0 110.299 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.5 p -89.32 153.16 21.1 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.0 0.428 . . . . 0.0 110.71 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.552 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.3 tm? -61.56 -35.05 76.67 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -67.08 -34.32 77.4 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.525 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 16.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 57.6 tp -64.02 -42.68 97.03 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 51.4 mtpt -56.13 -49.38 74.09 Favored 'General case' 0 C--O 1.165 -3.364 0 O-C-N 123.889 0.743 . . . . 0.0 109.433 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -58.27 -37.26 74.62 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 31.0 mmmt -68.39 -41.03 81.1 Favored 'General case' 0 N--CA 1.406 -2.654 0 C-N-CA 123.531 0.732 . . . . 0.0 110.257 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 77.8 mt -67.11 -40.9 86.96 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.842 0.857 . . . . 0.0 110.235 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 4.5 mm-40 -60.9 -30.62 70.28 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 125.029 1.332 . . . . 0.0 112.137 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.72 -25.43 65.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.476 0.655 . . . . 0.0 110.027 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.24 -41.85 13.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.546 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.89 -27.58 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.69 1.08 87.6 Favored Glycine 0 C--O 1.243 0.716 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.669 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 42' ' ' THR . 7.3 m -85.11 177.97 7.7 Favored 'General case' 0 C--O 1.261 1.689 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 41' ' ' THR . 5.0 m -110.69 156.24 21.3 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.0 t -58.13 -40.95 79.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -163.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.95 -17.82 60.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 121.871 -0.518 . . . . 0.0 111.949 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.5 m -91.63 -6.1 52.77 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 123.156 0.582 . . . . 0.0 111.171 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.533 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 40.5 tpp -102.08 125.31 48.73 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.32 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HG2' HE22 ' A' ' 49' ' ' GLN . 79.5 ttt180 -109.4 140.98 42.43 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.74 127.98 74.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.454 HE22 ' HG2' ' A' ' 47' ' ' ARG . 26.2 mp0 -112.8 142.61 45.23 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.901 0.48 . . . . 0.0 110.686 174.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 58' ' ' LYS . 5.3 tt -110.13 113.93 27.01 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.43 151.14 25.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.355 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' ASP . 17.8 t70 -80.71 177.31 9.11 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.434 0.635 . . . . 0.0 110.528 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.15 -33.15 69.13 Favored Glycine 0 C--N 1.291 -1.97 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -80.1 -67.95 0.72 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' ASP . 12.9 t70 178.24 -163.34 0.03 OUTLIER 'General case' 0 C--O 1.245 0.868 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 68.96 142.28 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.172 1.789 . . . . 0.0 112.758 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.8 tp -82.99 122.79 28.75 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.331 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 58' ' ' LYS . 7.8 mmpt? -83.6 -42.97 16.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.33 171.06 43.81 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.35 128.77 53.66 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 62' ' ' THR . 86.6 mt -92.13 -150.95 0.27 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.686 -174.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 61' ' ' LEU 0.259 2.3 t 99.58 4.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 127.821 2.448 . . . . 0.0 110.483 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 4.1 m-20 -62.22 -76.48 0.06 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.88 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 63' ' ' ASP . . . 60.26 8.36 8.8 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.4 -8.67 59.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.989 0.894 . . . . 0.0 109.138 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -131.72 -176.37 4.02 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.045 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.6 p -86.14 165.16 16.8 Favored 'General case' 0 N--CA 1.402 -2.847 0 CA-C-O 122.152 0.977 . . . . 0.0 111.205 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 28' ' ' LEU . 60.1 mt -69.11 -25.27 64.32 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.958 177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.41 -47.01 77.75 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.071 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.75 -31.72 72.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.655 0.74 . . . . 0.0 110.24 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.62 -12.85 60.88 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.606 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.78 19.63 61.2 Favored Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.91 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -87.38 88.11 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.875 0.845 . . . . 0.0 108.892 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -107.84 -172.06 1.99 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.47 149.51 44.1 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 111.051 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.01 -11.76 71.39 Favored Glycine 0 C--N 1.28 -2.552 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.17 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD21 ' A' ' 50' ' ' LEU . 83.3 m-85 -80.58 156.12 26.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.973 0.386 . . . . 0.0 111.059 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -115.17 121.35 42.72 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 7' ' ' LEU . 46.1 mm -105.52 123.94 60.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.051 0.453 . . . . 0.0 110.231 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -105.12 121.5 43.93 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.203 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -105.36 140.17 38.89 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 47' ' ' ARG . 13.7 p -138.76 132.26 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.156 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.89 124.03 27.83 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.995 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.25 -28.57 3.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 t -85.64 -32.09 22.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.88 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.73 -5.15 60.13 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.01 -167.42 21.94 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.7 -0.75 . . . . 0.0 114.032 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.85 128.66 45.93 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.959 0.409 . . . . 0.0 111.38 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.46 9.88 37.49 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.003 0.906 . . . . 0.0 110.411 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.872 178.062 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttm . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -88.25 113.15 23.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -169.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 36.7 mt-10 -159.84 101.18 1.45 Allowed 'General case' 0 CA--C 1.468 -2.207 0 C-N-CA 127.303 2.241 . . . . 0.0 107.585 169.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 21' ' ' LYS . 6.9 m -142.12 141.98 28.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.197 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -116.46 130.93 57.03 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.321 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -82.65 120.49 25.62 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -125.43 151.83 45.67 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.573 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -109.98 120.48 42.58 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mm -97.21 131.38 44.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.2 p -134.44 161.68 34.36 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.946 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.3 m -150.27 165.69 32.21 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' A' ' 88' ' ' ASN . 28.4 p-10 -85.98 -19.07 30.95 Favored 'General case' 0 C--N 1.254 -3.57 0 C-N-CA 123.482 0.713 . . . . 0.0 110.36 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.17 -26.44 23.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.205 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.2 p -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.246 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -110.95 -7.17 14.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.27 0.557 . . . . 0.0 110.373 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -100.53 118.89 60.14 Favored Pre-proline 0 C--N 1.306 -1.314 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.008 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.74 128.25 11.54 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 108.558 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.3 ttt -114.79 121.63 43.87 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.52 132.45 43.19 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.231 0.539 . . . . 0.0 111.201 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -145.79 147.7 32.15 Favored 'General case' 0 N--CA 1.409 -2.502 0 C-N-CA 124.311 1.044 . . . . 0.0 110.1 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 4' ' ' VAL . 84.5 tttt -111.31 116.66 31.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 64.0 m-85 -124.41 144.43 45.93 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 51.4 Cg_exo -56.74 144.21 87.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.386 2.724 . . . . 0.0 113.695 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 69' ' ' LYS . . . -57.71 -34.2 69.22 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.826 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.75 9.31 75.81 Favored Glycine 0 C--N 1.298 -1.549 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.017 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.9 tpt -77.22 157.33 30.91 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.3 p -89.72 147.21 23.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.181 0.515 . . . . 0.0 110.438 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 3.3 tm? -71.54 -28.88 64.17 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.432 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 88.8 m-20 -63.47 -32.81 74.36 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.65 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 21.8 t70 -70.88 -41.76 70.93 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.27 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 2.2 tm? -63.42 -43.45 97.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.681 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 18.1 mmmt -55.32 -53.31 57.69 Favored 'General case' 0 C--O 1.173 -2.949 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.154 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.78 -34.61 74.75 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 30' ' ' ASP . 1.5 mptm? -70.64 -34.29 71.92 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.92 176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 62.2 mt -69.88 -45.58 67.34 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.334 0.654 . . . . 0.0 110.077 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 51.3 mm-40 -59.3 -32.04 69.68 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 124.394 1.078 . . . . 0.0 109.888 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.95 -36.52 82.39 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.491 177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.24 -41.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.1 t -85.34 -22.54 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.246 0.546 . . . . 0.0 111.53 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.34 75.26 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 -178.74 4.76 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 121.356 0.598 . . . . 0.0 112.489 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.3 p -115.76 161.54 18.59 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.115 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.3 m -58.74 -45.27 91.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.39 -26.59 66.52 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.911 0.386 . . . . 0.0 111.686 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 85' ' ' THR . 30.1 t -84.79 -15.02 46.33 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.368 0.604 . . . . 0.0 111.411 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.582 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 42.8 tpp -110.36 112.38 24.29 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.643 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -97.09 136.46 37.6 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.401 ' CG1' ' HD3' ' A' ' 32' ' ' LYS . 48.3 mm -111.08 124.01 67.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.386 -177.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.532 HE21 HD11 ' A' ' 57' ' ' LEU . 32.4 tp60 -111.41 137.87 48.65 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 HD21 ' A' ' 61' ' ' LEU . 47.9 tp -111.85 118.27 35.09 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.52 135.76 43.56 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB3' ' HG2' ' A' ' 56' ' ' GLN . 15.7 t70 -68.68 -68.87 0.36 Allowed 'General case' 0 CA--C 1.497 -1.073 0 CA-C-O 121.767 0.794 . . . . 0.0 110.915 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.62 -90.66 1.37 Allowed Glycine 0 C--N 1.282 -2.469 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.182 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.05 -32.52 14.45 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -165.29 -34.9 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 6.3 pm0 -50.56 126.84 16.39 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.283 1.039 . . . . 0.0 112.52 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.532 HD11 HE21 ' A' ' 49' ' ' GLN . 43.8 tp -82.2 143.44 31.4 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 113.632 -1.622 . . . . 0.0 112.705 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -104.64 -39.33 6.4 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.022 174.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.0 -161.38 30.31 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -109.39 132.22 54.33 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.566 ' O ' ' HB ' ' A' ' 62' ' ' THR . 85.5 mt -79.63 -107.35 0.02 OUTLIER 'General case' 0 CA--C 1.477 -1.856 0 C-N-CA 119.236 -0.985 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 61' ' ' LEU . 36.8 m 79.09 -5.36 2.0 Allowed 'General case' 0 C--N 1.278 -2.527 0 CA-C-O 121.481 0.657 . . . . 0.0 112.357 169.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 71' ' ' LEU . 18.2 m-20 -110.91 119.41 38.99 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -113.83 -1.52 24.13 Favored Glycine 0 C--N 1.29 -1.994 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.04 -7.64 52.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.866 0.841 . . . . 0.0 109.668 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 17.4 ptmt -126.07 156.61 39.71 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.943 178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 9.3 m -78.18 166.95 22.13 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 120.735 0.302 . . . . 0.0 110.732 -172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.1 -34.66 72.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.221 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 88.5 tttt -71.93 -43.32 65.46 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.036 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 11.9 t70 -70.08 -25.62 63.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.593 0.711 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' ASP . 84.2 mt -74.58 -14.33 60.77 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.338 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.76 5.91 62.58 Favored Glycine 0 C--N 1.309 -0.958 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.552 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.46 116.31 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 77' ' ' TYR . 88.5 mtm180 -123.03 -174.73 3.01 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.27 144.46 40.29 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.069 0.462 . . . . 0.0 110.262 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.32 10.58 63.79 Favored Glycine 0 C--N 1.29 -1.998 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.653 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 74' ' ' ARG . 10.9 m-85 -103.83 157.16 17.27 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 122.982 0.513 . . . . 0.0 111.189 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -122.92 133.75 54.39 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 50' ' ' LEU . 32.7 mm -101.11 130.53 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -117.86 120.06 36.75 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.719 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -97.93 141.26 31.12 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.5 132.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -84.28 140.58 31.55 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-O 121.561 0.696 . . . . 0.0 110.507 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -96.75 -22.94 4.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.119 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.412 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 13.9 t -66.36 -32.49 73.91 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.57 -2.74 40.58 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 54.3 39.75 65.79 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 114.733 -0.733 . . . . 0.0 112.117 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.476 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 37.0 m-80 -86.62 121.65 29.44 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.634 -177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.35 21.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 122.811 1.291 . . . . 0.0 108.177 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.428 -1.559 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.304 -175.686 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 p -91.45 110.88 22.19 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 29.4 mt-10 -151.16 106.52 3.34 Favored 'General case' 0 CA--C 1.478 -1.813 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.477 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.13 149.43 33.59 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.906 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.623 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 24' ' ' ALA . 1.5 p90 -122.29 133.29 54.68 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.295 175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -97.24 115.8 28.27 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.27 157.75 35.85 Favored 'General case' 0 C--N 1.25 -3.76 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.91 114.69 28.68 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.739 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 79' ' ' ILE . 48.4 mm -95.84 130.13 44.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.678 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 80' ' ' HIS . 14.4 p -122.11 144.23 49.06 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 2.8 m -140.76 160.9 39.04 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.945 0.878 . . . . 0.0 109.246 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 82' ' ' VAL . 29.9 t30 -57.55 -34.93 69.68 Favored 'General case' 0 C--N 1.261 -3.282 0 C-N-CA 127.032 2.133 . . . . 0.0 111.341 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 9.3 19.47 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.0 p -114.93 137.89 51.46 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.709 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -88.97 -37.16 15.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.549 0.69 . . . . 0.0 109.187 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 91.9 m-85 -94.72 138.99 22.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.129 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 13.3 Cg_exo -71.95 140.21 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.385 2.057 . . . . 0.0 110.288 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.454 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 26.2 mmt -102.61 122.28 44.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.84 121.09 33.14 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' CE2' ' A' ' 22' ' ' TYR . 39.5 mmtm -134.8 138.31 44.15 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.182 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 38.8 ttpt -115.67 116.21 27.7 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 20' ' ' LYS . 85.0 m-85 -131.63 160.31 68.0 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 25.3 Cg_exo -64.32 142.56 79.83 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.296 1.997 . . . . 0.0 112.627 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' CE2' ' A' ' 5' ' ' TYR . . . -59.68 -29.66 68.23 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.748 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.44 1.74 88.29 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.777 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.7 tpp -82.22 151.35 26.9 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 122.356 -0.497 . . . . 0.0 110.269 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 51.5 p -85.28 152.85 22.99 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 123.359 0.663 . . . . 0.0 111.484 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 tt -58.39 -39.6 80.1 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.987 173.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -62.45 -45.34 93.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.703 -176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -37.01 70.28 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 120.978 0.418 . . . . 0.0 110.851 -177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HD11 ' A' ' 68' ' ' LEU . 5.6 tt -64.11 -48.97 74.05 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 20.9 mtpp -70.42 -36.44 74.0 Favored 'General case' 2 C--O 1.138 -4.774 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 178.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -59.44 -26.55 65.3 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 120.102 1.319 . . . . 0.0 110.065 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.18 -38.23 63.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 39' ' ' VAL . 82.2 mt -76.49 -42.71 42.48 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.302 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 57.1 mm-40 -59.09 -30.69 68.27 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 125.293 1.437 . . . . 0.0 110.364 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.83 -36.96 72.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.595 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.19 -33.9 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 123.112 0.565 . . . . 0.0 110.227 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 35' ' ' LEU . 60.0 t -78.41 -23.5 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 121.081 0.467 . . . . 0.0 111.215 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.96 10.84 85.94 Favored Glycine 0 C--N 1.308 -1.01 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.843 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 42' ' ' THR . 21.9 m -111.81 179.49 4.0 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.539 ' H ' HG22 ' A' ' 41' ' ' THR . 5.2 m -129.89 162.84 27.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.24 -27.86 40.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 120.936 0.398 . . . . 0.0 111.938 -173.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.88 -35.34 76.39 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.151 0.501 . . . . 0.0 111.617 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.0 m -96.14 3.38 53.29 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.576 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 52.7 tpp -110.11 135.95 50.1 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.351 -173.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.569 ' HB3' HE22 ' A' ' 49' ' ' GLN . 6.4 mpt_? -109.24 142.83 39.53 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.593 HG22 HD23 ' A' ' 61' ' ' LEU . 3.2 mp -124.32 120.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.721 0.296 . . . . 0.0 110.238 -173.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.569 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -112.2 143.56 43.05 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.602 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.797 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.3 tt -106.09 117.81 35.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -106.39 136.8 45.51 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -166.79 1.58 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.75 -18.15 66.36 Favored Glycine 0 C--N 1.282 -2.471 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 3.6 p30 -71.75 -76.24 0.11 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.74 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -179.23 -41.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.521 0.728 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 13.6 pt20 -81.9 147.38 29.32 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.64 123.48 21.0 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.565 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -84.0 -43.29 15.31 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.749 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.88 170.78 43.69 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.946 -1.597 . . . . 0.0 114.139 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.37 122.35 42.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 50' ' ' LEU . 1.6 mm? -84.29 -97.16 0.06 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 61' ' ' LEU 0.295 3.0 t 80.32 -3.13 1.92 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 128.424 2.689 . . . . 0.0 112.924 176.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.27 124.08 42.7 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 27' ' ' SER . . . -131.26 19.51 4.85 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.361 178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.56 -12.52 42.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HD3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -109.18 175.11 5.57 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.451 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 3.9 m -85.54 163.51 18.35 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 25.6 mt -71.05 -25.09 62.49 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.986 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 87.4 tttt -62.74 -42.17 99.54 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 66' ' ' LYS . 25.4 t70 -66.17 -32.36 73.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.277 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 68' ' ' LEU . 65.2 mt -74.18 -9.85 59.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.933 176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.12 14.7 50.83 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.224 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 52.0 t -93.85 118.96 40.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.369 0.604 . . . . 0.0 110.095 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -117.83 -163.4 0.93 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.83 146.75 49.5 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.24 5.42 82.79 Favored Glycine 0 C--N 1.282 -2.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 114.558 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -90.68 150.81 21.51 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 117.598 0.699 . . . . 0.0 112.105 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -105.19 120.73 42.25 Favored 'General case' 0 N--CA 1.393 -3.315 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 9' ' ' ILE . 47.6 mm -109.35 123.76 65.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.508 ' HD2' ' OE1' ' A' ' 49' ' ' GLN . 82.1 t60 -107.21 138.46 43.35 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.726 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.576 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -126.11 132.23 51.93 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . 7.7 p -134.2 131.42 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.92 140.96 34.49 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-O 121.611 0.719 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.45 2.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.31 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -93.25 -32.64 14.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.8 -0.28 56.4 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.714 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.86 170.39 44.36 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -81.7 135.41 35.51 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.58 91.68 0.09 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.963 1.305 . . . . 0.0 112.979 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 172.908 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.506 -0.732 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.5 m -76.9 111.92 12.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HG2' ' HB3' ' A' ' 24' ' ' ALA . 45.1 tt0 -156.49 113.33 3.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 152.66 29.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.079 0.942 . . . . 0.0 112.421 -174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.686 ' CD1' ' HA ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -124.97 130.96 53.41 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.067 -177.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.44 ' N ' ' HD1' ' A' ' 5' ' ' TYR . 9.3 m-20 -93.83 115.54 27.95 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 79' ' ' ILE . 4.5 mp -106.43 152.44 23.62 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -110.3 114.51 28.03 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.7 mm -95.23 135.37 29.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.754 -172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.7 p -137.35 155.76 49.02 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.113 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.0 m -149.04 167.55 25.54 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -67.8 -18.79 64.97 Favored 'General case' 0 C--N 1.279 -2.48 0 C-N-CA 123.283 0.633 . . . . 0.0 110.605 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.01 -1.46 34.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -107.41 128.61 54.63 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.699 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -94.28 -28.42 15.59 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.704 0.764 . . . . 0.0 109.272 175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 89.9 t80 -99.64 122.97 49.57 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.333 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 8.0 Cg_exo -72.27 128.46 13.8 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.323 2.016 . . . . 0.0 110.496 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -109.95 128.7 55.54 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.49 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -94.06 122.97 37.11 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -141.56 134.86 29.45 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.418 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.58 133.2 44.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.734 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -136.34 156.62 76.52 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 134.63 31.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.979 1.786 . . . . 0.0 111.207 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . . . -74.76 -15.43 60.76 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.97 0.414 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.43 4.78 64.57 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.425 ' HA ' ' CE ' ' A' ' 26' ' ' MET . 0.0 OUTLIER -87.5 166.46 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 26' ' ' MET . 14.3 p -83.1 142.74 31.04 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.847 0.356 . . . . 0.0 111.063 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.0 tm? -59.09 -34.34 71.88 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' CG ' ' HA3' ' A' ' 64' ' ' GLY . 95.6 m-20 -61.08 -31.32 70.99 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.39 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 18.7 t70 -75.99 -44.38 39.95 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' CD1' HD21 ' A' ' 68' ' ' LEU . 5.8 tt -62.31 -48.11 81.31 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.074 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -62.13 -36.45 81.81 Favored 'General case' 0 C--O 1.184 -2.39 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.114 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ASN . 1.9 tppp? -66.54 -23.09 66.17 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.606 0.762 . . . . 0.0 110.181 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 28.1 mmmt -84.01 -39.77 19.25 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.38 -32.98 60.97 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 113.583 -1.644 . . . . 0.0 110.332 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -54.97 -39.79 69.33 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 123.907 0.883 . . . . 0.0 110.073 171.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.29 -36.58 84.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.615 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.0 t -79.67 -41.88 22.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.309 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 t -87.89 -27.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 120.378 -0.529 . . . . 0.0 112.23 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.81 65.51 Favored Glycine 0 C--N 1.309 -0.919 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.223 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -71.62 169.89 14.6 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -124.33 165.45 17.66 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.6 t -59.38 -49.3 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -168.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.24 -25.33 59.58 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.701 0.762 . . . . 0.0 110.789 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -91.94 1.05 57.43 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.451 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.1 ttt -111.85 112.51 24.23 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HB3' HE22 ' A' ' 49' ' ' GLN . 53.7 mtm180 -96.53 144.19 26.84 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.207 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.02 119.47 60.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.242 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.489 HE22 ' HB3' ' A' ' 47' ' ' ARG . 26.4 mp0 -113.19 145.12 41.52 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 122.355 0.262 . . . . 0.0 111.246 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 61' ' ' LEU . 3.8 tt -108.23 116.07 31.29 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 96.5 m-85 -103.35 125.12 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 170.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 58' ' ' LYS . 8.8 t70 -87.68 -160.48 0.62 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-O 121.503 0.668 . . . . 0.0 110.488 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.99 -28.38 58.75 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 106.124 -2.791 . . . . 0.0 106.124 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 56' ' ' GLN . 17.9 t70 -78.95 144.57 34.67 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 171.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.32 -37.69 72.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HG2' ' OD1' ' A' ' 54' ' ' ASP . 12.5 pt20 -75.07 159.68 31.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tt -77.33 126.58 31.15 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.917 -1.492 . . . . 0.0 108.444 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 33.7 mmtp -82.76 -41.71 18.86 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.502 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.02 -177.4 48.26 Favored Glycine 0 C--N 1.281 -2.485 0 C-N-CA 119.782 -1.199 . . . . 0.0 111.668 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -111.14 127.06 55.45 Favored 'General case' 0 N--CA 1.405 -2.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 50' ' ' LEU . 6.3 mp -91.39 -144.93 0.19 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 124.395 1.078 . . . . 0.0 108.737 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 61' ' ' LEU 0.273 1.2 t 104.51 1.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 127.319 2.248 . . . . 0.0 112.251 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -86.43 112.08 21.14 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . -105.74 6.96 41.56 Favored Glycine 0 C--N 1.286 -2.249 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.361 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.66 -5.96 50.05 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.644 0.735 . . . . 0.0 109.487 175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.644 ' HE3' ' OD1' ' A' ' 70' ' ' ASP . 18.3 ptmt -136.76 164.51 28.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.204 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 7.1 m -85.05 168.06 15.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 31' ' ' LEU . 4.9 mp -62.73 -32.05 73.1 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -72.97 -42.53 63.24 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.474 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.644 ' OD1' ' HE3' ' A' ' 66' ' ' LYS . 10.9 t70 -67.63 -25.48 65.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.773 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.79 -13.61 60.97 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.15 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.89 34.87 23.35 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 t -111.51 118.17 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.94 172.46 7.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.686 ' HA ' ' CD1' ' A' ' 5' ' ' TYR . 5.2 p-10 -71.72 156.54 39.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.36 -4.02 85.32 Favored Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.75 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -89.64 157.61 17.94 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 51' ' ' PHE . 89.2 mtt180 -104.3 122.41 45.36 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 7' ' ' LEU . 44.2 mm -101.31 120.58 51.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-O 121.932 0.872 . . . . 0.0 109.32 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -107.96 131.37 54.62 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.543 -176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -111.78 145.62 39.06 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.69 138.91 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.988 0 CA-C-O 120.988 0.423 . . . . 0.0 110.891 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.95 131.88 35.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.914 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.64 -36.63 11.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.359 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.7 p -65.26 -26.42 68.09 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.83 -4.19 79.33 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.251 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.29 47.4 89.93 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -92.82 126.69 38.02 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.658 -0.271 . . . . 0.0 110.708 -177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 41.87 53.45 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.326 1.45 . . . . 0.0 114.527 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.402 -2.865 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.111 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 p -87.01 112.61 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.329 0.585 . . . . 0.0 110.264 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 42.3 tt0 -160.55 93.13 1.0 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.8 m -130.17 150.25 34.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.154 -171.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CE2' ' HG ' ' A' ' 7' ' ' LEU . 11.3 p90 -125.71 141.64 51.91 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.971 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -81.9 130.77 35.17 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.602 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.6 mp -114.64 153.06 30.85 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.0 tt0 -113.5 114.73 26.94 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 53.4 mt -106.88 128.3 61.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.447 0 CA-C-O 121.275 0.559 . . . . 0.0 111.942 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.5 p -117.82 158.25 25.13 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.766 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 8.1 p -136.3 164.85 27.15 Favored 'General case' 1 N--CA 1.378 -4.067 0 CA-C-O 121.398 0.618 . . . . 0.0 109.737 179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.562 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.92 -42.35 90.25 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 173.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.98 -39.46 61.27 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.371 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.4 p -120.74 127.15 51.73 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.904 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.08 9.13 26.51 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.299 0.571 . . . . 0.0 110.88 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -84.29 118.19 70.57 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.93 125.22 8.56 Favored 'Trans proline' 0 N--CA 1.441 -1.608 0 C-N-CA 121.994 1.796 . . . . 0.0 110.355 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.3 ttt -107.96 129.3 55.12 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.52 129.05 34.52 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -153.11 149.02 27.64 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -115.22 134.15 55.4 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 122.637 0.375 . . . . 0.0 111.409 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -132.54 160.28 68.94 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 123.681 0.792 . . . . 0.0 109.799 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.468 ' O ' HD12 ' A' ' 68' ' ' LEU . 6.1 Cg_exo -74.13 130.72 14.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.376 2.05 . . . . 0.0 111.923 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.82 -22.46 62.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.735 0.779 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.81 3.68 85.95 Favored Glycine 0 C--N 1.299 -1.472 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.307 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 13.2 tpt -97.22 168.96 10.11 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 117.255 0.528 . . . . 0.0 110.068 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.8 p -83.25 158.4 22.29 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 122.877 0.471 . . . . 0.0 110.321 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 61' ' ' LEU . 2.6 tt -71.54 -28.93 64.21 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.65 -32.54 71.7 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.172 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 20.7 t70 -68.25 -47.2 68.4 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.085 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 5.6 tt -62.5 -39.51 93.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -54.21 -51.71 63.55 Favored 'General case' 0 C--O 1.182 -2.475 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.161 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -68.45 -23.47 64.61 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 120.919 0.39 . . . . 0.0 111.014 -176.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 30' ' ' ASP . 72.5 mmtt -78.56 -43.23 27.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.78 -44.73 89.08 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 113.096 -1.865 . . . . 0.0 110.127 175.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 47.1 mm-40 -61.29 -30.71 70.65 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 123.43 0.692 . . . . 0.0 112.789 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.43 -31.17 71.83 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.07 -38.22 11.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.848 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.17 -28.4 13.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.36 14.77 81.83 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.609 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -119.88 -163.14 0.97 Allowed 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.1 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -101.44 163.33 12.32 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.237 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 m -58.91 -44.2 90.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.26 -23.49 61.99 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.281 0.563 . . . . 0.0 111.75 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.5 m -84.73 1.23 47.48 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.647 ' SD ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -134.96 119.51 18.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 26.0 tpt180 -104.1 142.14 35.0 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -172.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 79' ' ' ILE . 2.0 mp -117.77 129.33 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -112.93 145.59 40.48 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 124.127 0.971 . . . . 0.0 109.154 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 73' ' ' VAL . 37.1 tp -111.52 131.08 55.49 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.4 139.98 53.22 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -95.93 -171.22 2.29 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-O 121.274 0.559 . . . . 0.0 111.706 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.07 -15.64 67.64 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.184 -0.916 . . . . 0.0 114.017 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 56' ' ' GLN . 8.4 m-20 -92.76 10.59 30.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 117.29 0.545 . . . . 0.0 110.621 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 76.29 -23.27 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.438 1.495 . . . . 0.0 112.524 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' ASP . 11.3 pt20 -61.1 156.5 17.95 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 50' ' ' LEU . 59.9 tp -76.28 128.39 34.79 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.174 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -85.1 -43.44 13.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.58 176.8 38.58 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -100.72 126.51 47.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 mt -92.34 -146.61 0.22 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.913 -175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 61' ' ' LEU 0.276 5.0 t 104.49 -1.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 128.968 2.907 . . . . 0.0 112.811 -177.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' HB2' HD21 ' A' ' 71' ' ' LEU . 7.2 m-20 -84.0 111.3 19.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.1 7.67 29.07 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.906 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.66 60.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.799 0.809 . . . . 0.0 109.12 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 19.2 ptmt -124.13 169.96 11.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.022 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -87.34 166.59 14.75 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.374 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 23' ' ' PRO . 77.5 mt -63.65 -31.64 72.88 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.828 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -67.71 -46.9 70.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.251 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HE3' ' A' ' 66' ' ' LYS . 31.6 t70 -73.73 -20.94 60.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.486 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 63' ' ' ASP . 83.4 mt -75.85 -15.04 60.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.966 173.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.73 12.05 67.24 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.285 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.9 t -88.15 99.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.12 -178.68 3.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' CA ' ' HB2' ' A' ' 5' ' ' TYR . 9.1 p-10 -67.97 139.72 56.38 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 122.164 0.983 . . . . 0.0 111.725 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.97 -8.44 78.02 Favored Glycine 0 C--N 1.279 -2.625 0 CA-C-N 113.88 -1.509 . . . . 0.0 112.825 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -83.5 146.85 28.14 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' A' ' 8' ' ' GLU 0.26 39.8 ptt180 -109.2 133.67 52.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.548 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 48' ' ' ILE . 1.6 mp -103.86 124.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.218 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -109.63 128.9 55.55 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.334 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' HB1' ' SD ' ' A' ' 46' ' ' MET . . . -117.54 139.64 50.68 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 12' ' ' ASN . 7.3 p -122.98 131.74 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-O 121.638 0.732 . . . . 0.0 110.057 -177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.95 111.62 15.3 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.346 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.26 -40.05 16.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -73.9 -31.37 63.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.547 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.16 -4.07 72.03 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.574 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.26 171.37 9.6 Favored Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.287 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.562 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . 2.8 t-20 -83.08 122.94 28.99 Favored 'General case' 0 N--CA 1.42 -1.964 0 O-C-N 122.171 -0.605 . . . . 0.0 110.148 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 50.4 81.47 0.06 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.957 -178.272 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttm . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.9 p -99.11 111.87 24.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.968 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' PRO . 8.9 mp0 -111.84 150.03 30.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.51 138.88 51.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-O 121.143 0.497 . . . . 0.0 110.287 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 6.2 p90 -121.01 140.92 51.25 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.5 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -102.88 123.5 46.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 5' ' ' TYR . 81.0 mt -123.46 155.49 37.37 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.422 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 33.9 tt0 -109.68 113.79 26.85 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mm -95.78 133.47 36.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.729 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 p -124.16 160.93 26.74 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.3 m -151.86 166.82 30.24 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.638 ' ND2' HD22 ' A' ' 88' ' ' ASN . 30.7 p-10 -81.9 -13.12 57.99 Favored 'General case' 0 C--N 1.252 -3.651 0 C-N-CA 123.435 0.694 . . . . 0.0 110.902 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.98 -20.96 16.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.0 p -101.94 148.03 25.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -104.24 -37.08 7.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.002 0.43 . . . . 0.0 110.125 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 79.3 t80 -96.59 119.23 64.32 Favored Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.112 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' PHE . 36.1 Cg_exo -62.57 141.33 85.75 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.963 2.442 . . . . 0.0 112.227 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.9 ttt -103.64 122.19 44.49 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.05 120.72 43.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.813 0.339 . . . . 0.0 111.039 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.0 157.81 44.82 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.515 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ttmp? -106.53 122.56 46.55 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.822 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 91.1 m-85 -132.29 157.48 78.16 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 17.4 Cg_exo -69.2 141.63 48.08 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.47 2.114 . . . . 0.0 112.369 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 3' ' ' GLU . . . -64.0 -24.75 67.83 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.243 0.544 . . . . 0.0 112.011 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.28 -7.3 88.67 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.438 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.41 152.52 43.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 34.7 p -84.04 149.29 26.35 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 122.767 0.427 . . . . 0.0 110.515 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 64' ' ' GLY . 2.2 tm? -68.21 -26.52 65.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 95.4 m-20 -60.13 -34.78 74.0 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.954 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.45 -44.34 71.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 43.2 tp -65.01 -47.12 78.61 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.974 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 29' ' ' ASN . 19.9 ptpt -63.79 -34.58 78.21 Favored 'General case' 0 C--O 1.181 -2.543 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.808 178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 1.2 tpmt? -65.0 -35.78 82.31 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 25.4 mmmt -63.4 -43.3 97.95 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.848 1.259 . . . . 0.0 109.607 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 95.1 mt -69.07 -45.54 70.07 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.191 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.07 -32.03 65.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.82 1.248 . . . . 0.0 111.597 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.1 tp -73.82 -30.12 62.53 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.13 0.49 . . . . 0.0 110.565 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -89.05 -41.37 13.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -89.26 -21.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.017 0.437 . . . . 0.0 111.535 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.1 88.28 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.747 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 42' ' ' THR . 6.6 m -75.6 169.68 17.62 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 122.571 0.348 . . . . 0.0 110.569 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 41' ' ' THR . 48.8 p -103.87 176.34 5.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.95 0.5 . . . . 0.0 109.754 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.99 -47.79 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.64 -34.72 62.81 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.119 0.485 . . . . 0.0 111.511 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -82.31 -3.34 55.12 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.11 111.31 23.6 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HB3' ' CG1' ' A' ' 82' ' ' VAL . 23.7 tpt180 -101.92 136.78 41.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 28' ' ' LEU . 49.4 mm -120.3 119.96 61.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 120.814 0.34 . . . . 0.0 111.847 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 80' ' ' HIS . 26.5 mp0 -112.52 148.41 34.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.966 178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 77' ' ' TYR . 5.1 tt -109.88 121.77 45.99 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.12 153.06 34.41 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.437 0.695 . . . . 0.0 110.907 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 53' ' ' GLY . 16.1 t70 -111.55 -157.17 0.61 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA2' ' NH1' ' A' ' 78' ' ' ARG . . . -99.37 4.81 58.58 Favored Glycine 0 C--N 1.284 -2.315 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.239 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.85 -74.31 0.11 Allowed 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t70 172.72 -54.61 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.901 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.414 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -92.96 166.83 12.19 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.76 137.82 49.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 126.666 1.986 . . . . 0.0 111.822 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -89.97 -40.94 12.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.749 0.82 . . . . 0.0 111.364 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.73 166.17 38.31 Favored Glycine 0 C--N 1.301 -1.361 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.793 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.43 115.57 21.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD23 HD13 ' A' ' 71' ' ' LEU . 4.6 mp -86.1 -90.71 0.1 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . 0.251 63.7 p 81.05 -4.47 1.71 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 128.507 2.723 . . . . 0.0 114.158 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.76 127.26 40.63 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.59 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 28' ' ' LEU . . . -124.8 5.38 8.48 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.505 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.25 -20.63 63.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -112.07 168.99 9.16 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.774 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 11.5 p -90.22 167.96 12.3 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-O 121.108 0.48 . . . . 0.0 111.491 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 mm? -62.79 -28.13 69.78 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.569 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -65.58 -40.27 92.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.81 -33.4 62.2 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD13 HD23 ' A' ' 61' ' ' LEU . 80.5 mt -72.7 -13.07 61.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.928 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.58 23.49 53.41 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.993 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -93.86 115.72 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -103.15 -176.95 3.23 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.61 161.21 27.12 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.08 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.45 75.96 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' CD2' HD21 ' A' ' 50' ' ' LEU . 54.5 m-85 -107.36 155.88 19.51 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.439 0.637 . . . . 0.0 111.973 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH1' ' HA2' ' A' ' 53' ' ' GLY . 63.7 mtt180 -107.65 121.54 44.89 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.04 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 7' ' ' LEU . 46.9 mm -101.84 125.39 55.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 82.7 t60 -108.95 128.22 54.74 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.95 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 11' ' ' THR . . . -112.67 141.84 45.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 47' ' ' ARG . 11.7 p -144.01 134.0 20.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 85' ' ' THR . 1.4 p-10 -85.01 138.89 32.17 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.644 0.735 . . . . 0.0 109.124 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.62 8.64 8.4 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' ASP . 9.8 t -84.91 -33.72 22.68 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.115 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.46 -0.0 32.78 Favored Glycine 0 CA--C 1.48 -2.153 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.69 38.35 87.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.638 HD22 ' ND2' ' A' ' 12' ' ' ASN . 7.9 t30 -85.19 130.84 34.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -175.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 67.33 84.39 0.15 Allowed 'General case' 0 C--O 1.242 0.687 0 O-C-N 124.059 0.849 . . . . 0.0 109.818 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.612 . . . . . . . . 0 0 . 1 stop_ save_